US20130172990A1 - Method and system for plicating tissue in a minimally invasive medical procedure for the treatment of mitral valve regurgitation - Google Patents
Method and system for plicating tissue in a minimally invasive medical procedure for the treatment of mitral valve regurgitation Download PDFInfo
- Publication number
- US20130172990A1 US20130172990A1 US13/534,158 US201213534158A US2013172990A1 US 20130172990 A1 US20130172990 A1 US 20130172990A1 US 201213534158 A US201213534158 A US 201213534158A US 2013172990 A1 US2013172990 A1 US 2013172990A1
- Authority
- US
- United States
- Prior art keywords
- mitral valve
- plication
- retainer
- catheter
- guide catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2466—Delivery devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00292—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B2017/2901—Details of shaft
- A61B2017/2905—Details of shaft flexible
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B17/2909—Handles
- A61B2017/2912—Handles transmission of forces to actuating rod or piston
- A61B2017/2923—Toothed members, e.g. rack and pinion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B17/2909—Handles
- A61B2017/2925—Pistol grips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B2017/2926—Details of heads or jaws
- A61B2017/2927—Details of heads or jaws the angular position of the head being adjustable with respect to the shaft
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B2017/2926—Details of heads or jaws
- A61B2017/2932—Transmission of forces to jaw members
- A61B2017/2939—Details of linkages or pivot points
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B2017/2946—Locking means
Definitions
- the present invention relates to a device and method for treating the vasculature and internal organs of a patient. Particularly, the present invention is directed to a system and method for treating mitral valve regurgitation in the heart of a patient using direct plication annuloplasty.
- Catheter based devices are used to treat a wide variety of medical problems in a minimally invasive manner. Catheters are used to place and expand angioplasty balloons used to widen veins and arteries narrowed by plaque. Small scaffolds called stents have been introduced into the vasculature using catheter-based systems in order to prevent the restenosis of such vessels.
- mitral valve regurgitation is one of the problems that a catheter based device and system could be used to treat in a minimally invasive manner.
- Mitral valve regurgitation is the backflow of blood from the left ventricle into the left atrium due to an improper alignment of the leaflets of the mitral valve thereby causing an imperfect closure of the valve.
- a gap between the anterior leaflet and posterior leaflet of the mitral valve is created by the improper closure providing a conduit for blood to flow through the mitral valve in a retrograde manner from the left ventricle to the left atrium.
- This gap may be a congenital defect or may be caused by disease, i.e., ischemic or idiopathic cardiomyopathy and/or intrinsic degenerative disease of components of the mitral valve apparatus.
- CHF congestive heart failure
- the walls of the left ventricle are expanded or dilated which causes the papillary muscles to be displaced downward and/or outward resulting in a tethering of the chordae tendineae and subsequent tethering/pulling on the leaflets.
- the mitral annulus is dilated.
- the combination of the dilated annulus and the tethering on the leaflets prevents the leaflets from closing properly, thereby causing the problematic gap in the mitral valve.
- the resultant backflow through the mitral valve reduces the efficiency of the heart resulting in a need for the heart to beat faster and/or more forcefully in order to produce the same amount of blood flow.
- Mitral valve regurgitation may be asymptomatic in some patients but in other patients the reduction in blood flow and the resultant strain on the heart could result in arrhythmias, heart attack and possibly death.
- porcine heart valves or mechanical heart valves are used to replace the damaged or defective mitral valve.
- Such treatments require the use of open-heart surgery to accomplish the implantation.
- Such heterologous valves may be used in humans but often wear-out prematurely and additional open-heart surgery is required to replace such valves with additional heterologous or mechanical valves.
- Mechanical valves have been developed which may also be used as a replacement for a defective mitral valve, however, the implantation of a mechanical valve usually indicates long-term anti-coagulant therapy to prevent clots from developing around the valve that could lead to a dangerous embolism. Long-term anticoagulant treatment causes other problems such as unwanted internal and external bleeding and possibly strokes.
- annuloplasty Another open-heart surgical procedure for treating functional mitral valve regurgitation is annuloplasty.
- annuloplasty procedure a generally “D” shaped annuloplasty ring is implanted on the mitral valve annulus to reduce the size of the stretched mitral valve annulus, most importantly, the septal-lateral dimension and improve closing (or coaptation) of the valve thereby reducing regurgitation.
- the surgeon surgically attaches, i.e., sews, the annuloplasty ring to the mitral valve on the atrial side of the mitral valve.
- the annuloplasty ring is sewn to the annulus on a top portion (i.e., the atrial side) of the mitral valve.
- tissue generally grows over the annuloplasty ring, and a line of contact between the annuloplasty ring and the mitral valve will essentially enable the mitral valve to appear and function as a normal mitral valve by reestablishing coaptation of the mitral valve leaflets but the durability of the effect is variable and may decline within six months after the procedure.
- the therapies are not extensive, as a patient is only subjected to the therapies for a matter of weeks, e.g., until tissue grows over the annuloplasty ring.
- a second open-heart surgical procedure used in the treatment of degenerative mitral valve regurgitation is the Alfieri stitch procedure which the uses an edge-to-edge suture in the mitral valve.
- An edge-to-edge stitch is used to stitch together an area at approximately the center of a gap defined between the anterior and posterior leaflets of the mitral valve. Once the stitch is in place, the stitch is pulled in to form a suture that holds the anterior leaflet against the posterior leaflet. By reducing the size of the gap between the anterior leaflet and the posterior leaflet, the amount of leakage through the mitral valve may be substantially reduced.
- Durability has been a concern for Alfieri procedures done without the addition of an annuloplasty ring.
- use of the edge-to-edge procedure is only indicated in certain degenerative pathologies where the primary abnormality or gap between the leaflets is centrally located.
- ventricular assist devices Another method of treating mitral valve regurgitation is the implantation of a ventricular assist device.
- Such devices are expensive and difficult to implant and require the patient to use anti-coagulant therapy indefinitely. Long-term use of anti-coagulant therapy may result in unnecessary bleeding and strokes.
- Such ventricular assist devices are, therefore, indicated for use only in patients that would likely not survive without their use and are used to keep patients alive who are candidates for heart transplant surgery.
- Left ventricular assist devices are a “bridge” therapy rather than a final therapy.
- U.S. Pat. No. 6,619,291 to Hvlaka et al. discloses a minimally invasive method of performing annuloplasty including inserting an implant into a left ventricle and orienting the implant in the left ventricle substantially below the mitral valve. The implant and tissue around the mitral valve are connected and tension is provided to the implant in order to substantially reduce an arc length associated with the mitral valve.
- a catheter based system for treatment of mitral valve regurgitation uses a retainers adapted to be secured to the annulus of the mitral valve with flexible tensile members coupled to the retainers.
- a crimping device deployable through the catheter compresses a crimp onto the flexible tensile members after they are pulled toward one another to reduce the circumferential length of the annulus.
- the number of permanent implants required in order to achieve an initial effect, and commitment to these implants before success of effect is able to be determined are serious drawbacks.
- Rogers et al. describes a device and method for the treatment of mitral valve regurgitation using a minimally invasive procedure in which plications are made proximate the mitral valve of the patient and a retainer is placed to hold the plication.
- United States Patent Application No. 2007/0032797 discloses a device for reducing the size of the stomach having a corkscrew-shaped anchor for placement in the gastric wall.
- United States Patent Application No. 2007/0025737 to Messerly et al. discloses a surgical retainer having a generally helical shape and a device having jaws for grasping tissue into which the helical retainer may be driven.
- United States Patent Application No. 2007/0055335 discloses an electrode probe having a corkscrew-shaped distal tip for use in cardiology applications.
- Such a procedure should provide the physician with the ability to changes the effect on the mitral valve during the procedure before taking an irreversible action.
- the present invention provides a system and method for the treatment of mitral valve regurgitation.
- the method preferably uses a femoral retrograde approach of crossing the aortic valve. Access to the left ventricle is achieved through the aortic valve using the standard retrograde femoral artery approach utilizing a rounded crossing catheter (CC) preferably with a “J” or pigtail configuration.
- CC rounded crossing catheter
- a deflecting guide catheter is then sent over the crossing catheter into the left ventricle. When the distal end of the deflectable catheter is in the left ventricle the crossing catheter is removed.
- the deflectable guide is preferably, but need not be, positioned between the papillary muscles with the distal segment lying along the posterior wall of the left ventricle and its tip is pointing towards the underside of the posterior mitral valve annulus.
- a plication device is then introduced through the deflectable catheter and is advanced out of the distal end of the deflectable catheter and is directed at the underside of the mitral valve, more preferably into the subvalvular groove and positioned so as to be able to grasp and plicate the tissue of the mitral valve at or near the annulus.
- a test plication of the mitral valve annulus is created and the appropriateness of the plication is examined using imaging means such as TEE, ICE, TTE or fluoroscopy with or without contrast injection. If the plication is determined to be appropriate then a retainer is applied to the plication to retain the tissue in the plicated state. If the plication is not satisfactory then a retainer is not applied and the jaws of the plication device are released and the plicator is repositioned to plicate a different tissue target at or near the annulus of the mitral valve. Such “test” plications may be repeated a number of times prior to deploying the retainer.
- a single plication and retainer do not sufficiently reshape the mitral valve to correct the regurgitation then the original deflectable guide is repositioned and a second plicator with a retainer is introduced into the delivery guide and positioned and used in the same manner.
- a multi-retainer plicator can be used to provide the second or third retainers as necessary during the procedure without requiring the removal and reintroduction of the plication device.
- the first is a prolapsable or curved tip crossing catheter preferably having a “J” or pigtail configuration. This may be used with or without a guidewire.
- the crossing catheter is inserted in a stack or telescoped configuration with the second component, a deflecting guide catheter within which the crossing catheter is initially telescoped or stacked.
- the deflecting guide catheter is used to provide a means for guiding the plication device into proper position on the underside of the mitral valve preferably at the subvalvular region of the mitral valve at or near the annulus.
- the third component of the system is a plication device that has an end effector having opposing members at least one of which can be manipulated to open.
- the plication device is used to grasp tissue and also contains at least one retainer to retain the tissue in the plicated form if desired.
- the retainer in the preferred embodiment is a “C” shaped retainer having an end portion and two substantially perpendicular prongs that are pushed into the plicated tissue. The ends of the prongs may be compressed to increase the pressure on the plicated tissue and to prevent the retainer from being dislodged from the plicated tissue.
- the present invention is a method for the percutaneous treatment of mitral valve regurgitation by reshaping a mitral valve annulus through an arterial access site in a patient comprising the steps of inserting a crossing catheter and a deflecting guide catheter having a lumen therethrough ending in a distal opening into the arterial access site of the patient; advancing the crossing catheter through the aortic valve into the left ventricle; advancing the deflecting guide catheter over the crossing catheter through the aortic valve into the left ventricle; withdrawing the crossing catheter from the patient; positioning the deflectable guide catheter with the distal opening pointing towards the underside of the mitral valve annulus; introducing a plication device into the arterial access site through the lumen of the deflectable guide catheter and advancing the plication device out the distal opening of the deflectable guide catheter; positioning the plication device at a first position in on the underside of the mitral valve at or near the annulus; plicating a first portion of tissue of the mitral valve using the plication device to create
- the method can include the steps of examining the first tissue plication using an imaging method to produce an image of the mitral valve; and, determining if the plication is acceptable prior to the step of applying the retainer. Furthermore, the method can include the steps of: releasing the plication if the plication is determined not to be appropriate at the examining step; repositioning the plication device at a second position in the subvalvular groove of the mitral valve annulus; and plicating a first portion of tissue of the mitral valve at or near the annulus using the plication device to create a first tissue plication.
- the method may also include the steps of: determining if the first tissue plication as retained by the retainer sufficiently reshapes the mitral valve annulus to treat the mitral valve regurgitation; repositioning the deflectable guide catheter to a second position on the underside of the mitral valve at or near the annulus; introducing a second plication device or using a reloaded multi-retainer plication device in the delivery guide catheter and positioning the second plication device in the subvalvular region of the mitral valve; plicating a second portion of tissue of the mitral valve at or near the annulus using the plication device to create a second tissue plication; and; applying a retainer to the second tissue plication.
- the method may include the steps of withdrawing the deflectable guide catheter and the plication device and closing the arterial access site.
- the present invention is directed to a system for the treatment of mitral valve regurgitation through direct plication annuloplasty of a patient that includes a deflecting guide catheter having an elongate body with lumen therethrough ending in a distal opening for insertion through the aortic valve into the left ventricle of the patient, a plication device having a set of opposing jaws operable to plicate tissue in the mitral valve of the patient, wherein the plication device comprises at least one retainer for retaining plications in tissue.
- the system includes a crossing catheter having a distal end for insertion through the aortic valve into the left ventricle of the patient.
- the crossing catheter may be J-shaped or pigtail shaped.
- the system may also include a guidewire for use in guiding the crossing catheter through the vasculature of the patient and into the left ventricle.
- the retainer is preferably “c” shaped and comprises two prongs having ends connected by an intermediate member.
- the present invention also includes a method for the percutaneous treatment of mitral valve regurgitation by reshaping a mitral valve annulus through a venous access site in a patient including the steps of accessing the right atrium through the venous access site with a transseptal access catheter; puncturing the septum using the transseptal access catheter; advancing the deflecting guide catheter over the transseptal access catheter through the transseptal puncture into the left atrium; withdrawing the transseptal access catheter from the patient; positioning the deflectable guide catheter with the distal opening pointing toward the mitral valve annulus; introducing a plication device into the venous access site through the lumen of the deflectable guide catheter and advancing the plication device out the distal opening of the deflectable guide catheter; positioning the plication device at a first position at or near the annulus of the mitral valve in the left atrium; plicating a first portion of tissue of the mitral valve using the plication device to create a first tissue plication; and applying
- the transseptal method may further include the steps of examining the first tissue plication using an imaging method to produce an image of the mitral valve; and, determining if the plication is acceptable prior to the step of applying the retainer; releasing the plication if the plication is determined not to be appropriate at the examining step; repositioning the plication device at a second position at or near the mitral valve annulus; plicating a first portion of tissue of the mitral valve at or near the annulus using the plication device to create a first tissue plication; determining if the first tissue plication as retained by the retainer sufficiently reshapes the mitral valve annulus to treat the mitral valve regurgitation; repositioning the deflectable guide catheter to a second position at or near the mitral valve annulus; introducing a second plication device or using a reloaded multi-retainer plication device in the delivery guide catheter and positioning the second plication device at or near the mitral valve annulus; plicating a second portion of tissue of the mitral
- FIGS. 1A and 1B are a flow diagram describing the method of treating mitral valve regurgitation in accordance with the present invention.
- FIGS. 2A-H depict the stages of the various steps of the method of treating mitral valve regurgitation in accordance with the present invention.
- FIG. 3 depicts the plication regions in the method of treating mitral valve regurgitation in accordance with the present invention.
- FIG. 4 is a perspective view of a crossing catheter for use in treating mitral valve regurgitation in accordance with the present invention.
- FIG. 5 is a cutaway view of a portion of the body of the crossing catheter of FIG. 4 .
- FIG. 6 is an elevational view of a deflecting guide catheter for use in treating mitral valve regurgitation in accordance with the present invention.
- FIGS. 7A and 7B are an exploded view and a perspective view respectively of the components of a handle for the deflecting guide catheter of FIG. 6 .
- FIG. 8 is an elevational view of the body portion of the deflecting guide catheter of FIG. 6 .
- FIGS. 9A and 9B are cross-sectional views of the body portion of the deflecting guide catheter of FIG. 8 taken through lines A and B respectively.
- FIGS. 10A-10C are perspective views of the body portion of other embodiments of a deflecting guide catheter for use in treating mitral valve regurgitation
- FIG. 11 is an exploded perspective view of another embodiment of the handle and internal components used in a deflecting guide catheter in accordance with the present invention.
- FIG. 12 is an elevational view of a plication device for use in treating mitral valve regurgitation in accordance with the present invention.
- FIG. 13 is an elevational view of the plication device of FIG. 12 with a portion removed to expose the internal components.
- FIG. 14A is an elevational view of the plication device of FIGS. 12 and 13 from the shuttle assembly to the distal end.
- FIG. 14B is a cross sectional view of the portion of the plication device of FIG. 14A taken through line A-A.
- FIG. 14C is an enlarged view of proximal end section D of the cross-sectional view of the portion of the plication device of FIG. 14B .
- FIG. 14D is an enlarged view of distal section C of the cross-sectional view of the portion of the plication device of FIG. 14B .
- FIG. 14E is an enlarged view of the distal tip section B of the cross-sectional view of the portion of the plication device of FIG. 14B .
- FIG. 14F is an enlarged planar view of the distal tip of the plication device of FIG. 14A .
- FIG. 14G is a detailed perspective view depicting the coupling of the end-effector control wire to the distal puller wires.
- FIG. 14 H is a detailed perspective view depicting the coupling of the end-effector control wire to the distal puller wires in an embodiment of the plication device having passive articulation.
- FIG. 15 is a perspective view of a retainer for use in a plication device for use in the treatment of mitral valve regurgitation in accordance with the present invention.
- FIGS. 16A-16D are elevational views of the distal end of various embodiments of a plication device in accordance with the present invention.
- FIG. 1 is a flow diagram depicting a method of providing direct plication annuloplasty to the mitral valve in a heart such as that depicted in FIG. 2A in accordance with the present invention.
- the procedure begins with a puncture for access to the femoral artery using standard techniques.
- the physician or other practitioner places a catheter sheath introducer (CSI) into the femoral access point using standard techniques. Any known CSI may be used in the procedure with the preferable size being approximately 14 french.
- CSI catheter sheath introducer
- Any known CSI may be used in the procedure with the preferable size being approximately 14 french.
- a crossing catheter, preferably prolapseable or having a curved tip, and a deflecting guide catheter are inserted together in a “stack” formation through the CSI.
- the deflecting guide catheter is inserted through the CSI without a crossing catheter although the use of a crossing catheter is the preferred method.
- the crossing catheter is described herein in greater detail with respect to FIGS. 4 and 5 below and the deflecting guide catheter is described herein in greater detail with respect to FIGS. 6 to 11 .
- the stacked crossing catheter and deflecting guide catheter are advanced through the arterial system of the patient traversing the aorta of the patient in a retrograde manner at step 106 .
- the aortic valve (AV) is crossed with the crossing catheter and the crossing catheter is advanced into the left ventricle (LV) as depicted in FIG. 2B .
- the deflecting guide catheter is advanced over the crossing catheter through the aortic valve and into the left ventricle as depicted in FIG. 2C .
- the deflecting guide catheter is deflected in a somewhat retroflexed manner as it is advanced approximately toward the mitral valve at step 112 as depicted in FIG. 2D and the crossing catheter is withdrawn at step 114 .
- a guidewire may also be used with the crossing catheter and deflecting guide catheter in a three-element stack inserted in the CSI. If a guidewire is used it is advanced first through the arterial system and over the aortic arch followed by the combined stack of the crossing catheter and the deflecting guide catheter. The guidewire is introduced first through the aortic valve followed by the crossing catheter which is preferably oriented into a position between the papillary muscles although this is not necessary. The procedure then continues as in steps 110 and 112 above with the guidewire removed simultaneously with the crossing catheter at step 114 .
- step 116 a region of the deflecting guide catheter is seated toward the mitral valve in the apex of the left ventricle as in FIG. 2E .
- the tip of the deflecting guide catheter is advanced up the posterior wall of the left ventricle to a position under the mitral valve, preferably initially placed in the subvalvular groove in the P2 region of the as shown in FIG. 3 .
- the term “annulus” is meant to include regions at or near the annulus.
- the position of the tip of the deflecting guide catheter is confirmed by using an imaging method such as fluoroscopy.
- P2 is the likely target region for a first retainer although depending on the geometry of the mitral valve the first retainer may be placed in region P1 or region P3. Additional retainers may need to be placed in the same or other regions.
- a plication device 400 loaded with one or more retainers is inserted into the deflecting guide catheter and advanced to the tip of the deflecting guide catheter.
- a plication device for use in this method is described in greater detail herein with respect to FIGS. 12 through 14H .
- the rotational orientation of the jaws of the plication device is determined using an imaging method and the jaws are placed in the correct orientation.
- the preferable rotational orientation for the jaws of the plication device is such that both tips of the jaws once opened would represent a “chord” of the arc defined by the mitral valve annulus when pushed into contact with the annulus.
- the plication device is advanced out of the end of the deflecting guide catheter into position under the annulus of the mitral valve as depicted in FIG. 2E .
- the orientation and position of the plication device is reconfirmed at step 128 using an imaging method. Again, if fluoroscopy is used as the imaging method, at least one and preferably two views are be used to confirm orientation and placement of the jaws of the plication device.
- An injection of a known contrast agent either using a separate contrast catheter or through the deflecting guide catheter may be used to help define the line of the annulus as viewed under fluoroscopy.
- a decision is made by the physician whether or not the jaws of the plication device are properly positioned.
- step 134 an attempt is made to reposition the jaws of the plication device.
- step 136 the position of the plication device is evaluated again using an imaging method as described previously and in more detail below. If the plication device is positioned correctly then step 132 and onward are performed as discussed below. If the plication device is not positioned properly after at least one attempt at repositioning at step 134 then step 138 results in a determination that the plication device cannot achieve a desired position and the plication device and deflectable guide catheter are withdrawn from the patient at step 150 .
- a diagnostic clamp or plication is performed at step 132 .
- the jaws of the plication device are opened as depicted in FIG. 2F
- the plication device is advanced onto the tissue of the annulus of the mitral valve and the jaws are closed as depicted in FIG. 2G .
- the diagnostic plication is evaluated at steps 140 , 142 and 144 . If the diagnostic plication results in an acceptable change in the mitral valve annulus and/or an acceptable reduction in mitral valve regurgitation then a retainer is applied using the plication device at step 140 and the plication device is released as depicted in FIG. 2H .
- Embodiments of a retainer that may be applied to the tissue are described in greater detail herein with respect to FIG. 15 .
- the diagnostic plication results in an unacceptable change to the mitral valve then the procedure is abandoned and both the plication device and the deflectable guide catheter are withdrawn from the patient at step 150 .
- the diagnostic plication results in an insufficient or inadequate reduction in mitral valve regurgitation (MR) and/or insufficient or inadequate change in the mitral valve then the diagnostic plication is released and an attempt to reposition the jaws of the plication device is performed at step 134 .
- MR mitral valve regurgitation
- a determination regarding the impact of the plication on the regurgitation of the mitral valve is made using a method of imaging the flow of blood through the valve such as Doppler echocardiograpy.
- steps 146 , 147 and 148 various decisions are made regarding the procedure and continuation of the procedure.
- the procedure branches to step 150 with the retrieval of the plication device and the deflecting guide catheter.
- step 147 the plication device currently in use is withdrawn if it is a single retainer device and an additional plication device is inserted and the procedure continues from step 122 . If the plication device is a multi-retainer device then the procedure continues from step 124 without withdrawal of the plication device. If the determination regarding the impact of the plication on mitral valve regurgitation results in a finding of an adverse result at step 148 then the procedure will likely be abandoned and both the plication device and deflecting guide catheter are removed from the patient at step 150 . After removal of the plication device and the deflecting guide catheter, the catheter sheath introducer is removed and the access site is closed at step 152 using known methods.
- Fluoroscopy is one real-time imaging modality that is useful, preferably, where images are taken in at least two planes. Radiopaque markers placed on the distal end of the plication device and/or deflecting guide will aid in determining proper placement.
- a three-dimensional profile of the plication device can be created using x-ray images acquired in at least two planar projections in real-time. Alternatively, rotational angiographic imaging may be used. Additionally, registering pre-acquired CT or MRI image data with the fluoroscopic image will provide additional anatomic data to the physician to aid proper placement of the plication device and retainer or retainer. Similarly, a three-dimensional real-time ultrasound image acquired in real-time may be registered with the fluoroscopic image.
- ICE intracardiac echocardiography
- the ICE image may be produced by an ICE catheter placed inside one of the chambers of the heart such as the right ventricle, left ventricle, left atrium or the right atrium.
- the ICE catheter could be placed inside on of the great vessels of the heart of the patient.
- the ICE catheter may also be placed on the epicardial or pericardial sack surfaces of the heart via a minimally invasive approach such as a sub-xiphoid approach.
- the images of the mitral valve should be taken synchronized to the cardiac cycle.
- Various imaging modalities are also useful in determining whether the plication achieves the desired impact on the function of the mitral valve in real-time or near real-time prior to applying the retainer to the plication.
- Real-time means that the latency period is acceptable to perform the procedure and is preferably no more than 500 milliseconds.
- Color Doppler ultrasound imaging may be used for such a purpose with or without an ultrasound contrast agent being administered to the patient.
- x-ray fluoroscopy could be used in determining the impact of a plication on mitral valve regurgitation by using an x-ray contrast bolus injection into one of the chambers of the heart, preferably the left ventricle.
- Bi-planar angiographic imaging or intra-chamber optical imaging may also be used. If intra-chamber optical imaging is used it is preferable that the deflecting guide catheter further comprise an optical imaging system particularly one that operates in infrared wavelengths.
- Determining a location for the first tissue plication may be based on an optimization plan generated using a three-dimensional functional numerical simulation based on imaging data generated by one or more of the aforementioned imaging method. For example, by analyzing the distribution of annular tissue relative to the location of the primary regurgitant flow through the valve, a primary target for initial plication therapy may be determined. It may be desirable to place the plication at the location of greatest distortion of the annulus due to the pathology of the patient's heart.
- the generation of the optimization plan may be performed prior to step of inserting the crossing catheter.
- the generation of the optimization plan may be performed after the step of applying a retainer to the first tissue plication in order to determine the preferred location for subsequent plication or plications.
- the plications could be made on the atrial surface if a transseptal approach is used. This can be accomplished by accessing the right atrium using SVC or IVC venous approaches. Then access the left atrium is accomplished using a standard transseptal puncture/access kit such as a Brockenbrough transseptal needle kit. The deflecting guide catheter would then be introduced through the puncture and deflected such that the tip pointed towards the annulus of the mitral valve. The subsequent steps and devices for a plication annuloplasty procedure would then be the substantially the same as set forth above except that the approach is from the atrial side of the mitral valve rather than the underside.
- FIG. 4 is a perspective view of a crossing catheter 200 for use in the procedure described in the present application.
- Crossing catheter 200 is comprised of a body portion 210 having a proximal end 210 a and a distal end 210 b .
- Connected to proximal end 210 a are a female luer lock 216 and a Tuohy-Borst hemostasis valve 214 .
- Pigtail 218 is approximately 2.0 centimeters or less in diameter.
- pigtail 218 is attached to body portion 210 at a splice location that is approximately 4 centimeters from the distal end of the device.
- Pigtail 218 is attached to body portion 210 using heat bonding as the body portion 210 and pigtail 218 re made from the same or similar material.
- Pigtail 218 is comprised of a polymer, preferably, Pebax® polyether block amide having a durometer of approximately 55 D if comprised of one layer or two layers having durometers of approximately 40 D in the outer layer and 55 D in the inner layer.
- Body portion 210 may be comprised of one layer having a durometer between 55 D and 72 D or may have two layers. If two layers are used the preferred durometers are 70 D for the outside and 63 D for the inside.
- the total length of the body portion and pigtail together is approximately 149 centimeters and should extend beyond the deflecting guide catheter when fully inserted into the deflecting guide catheter thus the length of the crossing catheter may vary depending on the length of the deflecting guide catheter used.
- the location at which the pigtail may be attached to the body portion may also vary from 3 centimeters to approximately 44.5 centimeters from the distal tip of the crossing catheter 200 .
- the crossing catheter may also be comprised of one material from the body portion through the pigtail. In such a case the use of an outer material with a durometer of 55 D and an inner material with a durometer of 40 D is preferred.
- a flat wire braid 212 of flat wires of approximately 0.001′′ by 0.003′′ may be embedded in the polymer comprising the proximal portion of body portion 210 in order to provide extra stiffness and torqueability.
- An inner layer 211 of PTFE provide a lubricious inner coating and a separation between the polymer and the inner lumen.
- the stiffness of the pigtail portion of the crossing catheter is chosen so that a standard guidewire such as the Cordis Emerald 0.035′′ guidewire will open up the pigtail yet will return to the pigtail shape when retracted.
- a standard guidewire such as the Cordis Emerald 0.035′′ guidewire will open up the pigtail yet will return to the pigtail shape when retracted.
- Such a guidewire is placed in the guidewire lumen defined by the inner layer 211 of the crossing catheter and should extend through the entire length of the crossing catheter.
- Crossing catheter 200 may be used with or without a guidewire as described above and is preferably used in conjunction with the deflecting guide catheter depicted in FIGS. 6 through 10 A-C.
- Deflecting guide catheter 300 is comprised of a handle 310 and a body portion 350 .
- FIG. 7A is an exploded view of an embodiment of the handle 310 depicting the internal components of the handle and
- FIG. 7B is a perspective view of the internal components of handle 310 as assembled.
- Handle 310 is comprised of upper handle shell 312 and lower handle shell 314 which are made of a durable moldable polymeric material such as polycarbonate or other similar material and are designed to mate with one another in a snap fit arrangement.
- a hemostasis valve 316 which is adapted to fit onto the proximal handle tip 318 .
- Hemostasis valve 316 may be of any known design for such a valve such as a tuohy-borst type valve.
- Proximal actuator assembly 324 is comprised of a thumb actuator 324 a that is adapted to be inserted through slot 313 in the upper handle shell 312 .
- a two-piece construction with a thumb cap 325 may be used to facilitate assembly if slot 313 is narrow.
- the thumb actuator 324 a and optional thumb 325 cap are used to cause forward motion in the proximal direction of puller wire 327 a .
- Such motion is retained as the prong or prongs 324 e biased by spring 324 d around pivot point axel pin 324 c engages the teeth 322 a in proximal rack 322 .
- Such proximal motion of the proximal actuator assembly 324 and the associated puller wire 327 a causes the deflection of the distal end of the deflecting guide catheter 300 .
- the user pushers release trigger 324 b which counters the bias of spring 324 d thereby releasing prong or prongs 324 e from engagement with the teeth 322 a of the proximal rack 322 .
- Proximal hypotube 331 a provides a passage way for puller wire 327 a and prevents kinking of the wire.
- Distal hypotube 331 b is designed to telescope inside hypotube 331 a .
- crimp tube 334 a At the end of puller wire 327 a are fixedly attached crimp tube 334 a and a floating crimp tube stop 334 b that prevents the crimp tube from being embedded in the proximal end of the actuator assembly.
- the user may then move the actuator assembly distally thereby changing the deflection of the distal end of the deflecting guide catheter. Movement of the actuator assembly may be made by the physician using something other than his or her thumb and the terms “thumb actuator” and “thumb cap” are not meant to be limiting.
- Handle 310 further comprises a distal actuator assembly 328 having a similar thumb actuator 328 a , release trigger 324 b , axel pin 324 c , spring 328 d and prong 328 e .
- Optional thumb cap 329 is affixed over thumb actuator 328 a .
- the distal actuator assembly 328 is connected to a second pullerwire 327 b (shown in FIG. 11 ) that enables the user to cause deflection of the distal end of the deflecting guide catheter.
- first and second puller wires are attached (through known methods and means such as welding, brazing or adhesives) to anchor bands 385 a and 385 b that are embedded in the distal region 360 of the body portion 350 of the deflecting guide.
- the puller wires and their respective anchor band connection points may also be arranged so that they are not next to one another (in an axial manner) but so that each provides motion of the distal end in another plane or in the other direction within the same plane.
- the second puller wire and actuator are not necessary if it is only necessary to provide one type of movement in the deflecting guide catheter.
- additional thumb actuator assemblies coupled to puller wires and anchor bands may be added in a similar manner to the catheter.
- the second distal actuator assembly has the same components as functions in the same manner as the proximal actuator assembly.
- the primary difference is that the distal actuator assembly 328 requires a passageway for passage of the first puller wire 327 a through the distal assembly which passage is aided by hypotube 331 b .
- the second puller wire 327 b ends at the distal end with a similar crimp tube 335 a and crimp tube stop 335 b .
- Nose cone 330 provides a transition between the handle shell 312 / 314 and the proximal region 390 of the body portion 350 .
- Acuator assemblies 324 and 328 and racks 322 and 326 are comprised of a polymeric material such as polycarbonate. Such assemblies could be made of machined or molded metal, such as aluminum, although that would result in a higher cost and weight device.
- Racks 322 and 326 with teeth 322 a and 326 a may be separate components or may preferably be molded into the lower handle shell 314 as depicted in the alternative embodiment shown in FIG. 11 .
- Handle insert 338 is used as a divider between the two racks 322 and 326 and provides a support for proximal hypotube 331 a .
- Puller wires 327 a and 327 b are preferably high tensile strength 304 stainless steel (e.g. tensile strength greater than 300 ksi) but may also be made of other high strength materials such as MP35N, other stainless steel, or woven fibers such as Kevlar or Vectran.
- Puller wires 327 a and 327 b are preferably a single, solid core high tensile strength 304 stainless steel wire (e.g. tensile strength greater than 300 ksi) of approximately 0.008′′ in diameter but may also be made of other high strength materials such as MP35N, other stainless steel, or woven fibers such as Kevlar or Vectran.
- an anchor band 385 a or 385 b that is embedded in the wall of the catheter body at the point of anchoring. Changing the location of the anchor band along the axial length of the catheter body will change the deflection profile of the deflectable guide catheter.
- Body portion 350 of deflecting guide catheter 300 is depicted in FIG. 8 and FIGS. 9A and 9B .
- Body portion is separated into four regions: distal region 360 , intermediate distal region 370 , main intermediate region 380 and proximal region 390 .
- Distal region 360 at the distal end is approximately 3.5 centimeters in length and is made of a polymeric material such as Pebax with a durometer of between 25 D and 40 D and preferably 35 D.
- a radiopaque material such as bismuth subcarbonate is added to the material in distal region 360 to enable the distal region 360 of the deflecting guide catheter 300 appear in fluoroscopy and other imaging procedures.
- the wall thickness in the distal region 360 is between approximately 0.012 and 0.014 inches.
- the anchor band 385 a for the first puller wire is embedded near the distal end of distal region 360 and the anchor band 385 b for the second puller wire is embedded near the proximal end of distal region 360 or at the distal end of region 370 .
- the anchor bands are preferable placed between the lubricious liner 365 and the braid 385 although it could be placed above the braid in an alternative embodiment.
- Each anchor band is made of 304 stainless steel and each puller wire is attached to its respective anchor band using welding or other means for joining metal that is known in the art.
- the internal diameter of distal region 360 as well as the entire body portion is defined by a lubricious liner 365 preferably PTFE that has an interior diameter of approximately 0.127 inches and is approximately 0.002 inches thick.
- the outer diameter of distal region 360 is approximately 0.172 inches between the anchor bands and approximately 0.176 inches at the location of the distal band.
- a braid 375 of wires having a diameter between 0.0025 and 0.003 inches in a 1 over 1, 1 over 2 under 2 or 2 over 2 pattern is embedded in the polymeric wall of the catheter from the proximal region 390 to the distal region 360 .
- At the distal end of the distal region 360 of deflecting guide 300 is an extruded atraumatic tip 362 comprised of 33.5% 25 D Pebax, 6.4% 55 D Pebax and 60% bismuth subcarbonate and having a slight taper toward its distal end.
- the atraumatic tip is optional although preferred in order to avoid tissue damage during insertion in the vessels of the patient.
- Intermediate distal region 370 is comprised of the same type of polymeric material but has a higher durometer of between 35 D and 55 D to provide a stiffer region. Intermediate distal region 370 is between approximately 2.8 and 4.0 centimeters in length and contains the same lubricious liner 365 and wire braid 375 as the distal region. The wall thickness in the intermediate distal region is similarly between 0.012 and 0.014 inches and the outer diameter is approximately 0.172 inches.
- Main intermediate region 380 has a slightly smaller outer diameter at 0.166 inches but has the same lubricious liner and braid as the other regions. The main difference in this region is the higher durometer of between 55 D and 63 D for the polymeric material used in order to provide increasing stiffness.
- the main intermediate region is approximately 20 to 28 centimeters in length, preferably 20 centimeters.
- Proximal region 390 has a similar composition in that the outer diameter is the same as the immediately prior region.
- the durometer in this region is increased to approximately 72 D providing even greater stiffness and the length of this region is approximately 73 to 88 centimeters, preferably 88 centimeters.
- the lubricious layer 365 and braid 375 are the same.
- first and second anchor bands 385 a / 385 b run two wire or braid reinforced tubes 395 a / 395 b of approximately 0.0088 inches in internal diameter which house the first and second puller wires respectively.
- One puller wire, anchor band and reinforced tube could be used instead of two.
- the braid may be changed to a different size wire and braid type.
- the polymeric material of the outer body may be varied as depicted in FIGS. 10A-10C . In FIG. 10A materials having two different durometers are used in an alternating fashion.
- Material A is used in two circumferential portions opposite one another while material B is used in two other opposing circumferential portions.
- the durometer of material A may be greater than the durometer of material B or vice versa depending on the deflection characteristics desired.
- Use of two different durometer materials in such a way provides the benefit of balancing the ability or ease of the catheters to deflect in a particular direction with the requirement for lateral stiffness.
- FIG. 10B two circumferential portions of material A and material B are used to provide a certain desired deflection characteristic.
- FIG. 10C the use of two different durometer materials is used in conjunction with placement of the puller wires 327 a and 327 b at different places along the circumference of the body portion. In the configuration in FIG.
- the distal end of the deflecting guide catheter would deflect in two different planes substantially perpendicular to one another.
- the plane of deflection is primarily determined by the relative placement of the puller wire lumens.
- the deflecting guide catheter may further comprise a magnetic based location sensor such as those manufactured by Biosense Webster for sensing the location and orientation (six degrees of freedom) of the distal end of the deflecting guide catheter and for providing location information that may be registered with other preaquired or real-time images or otherwise used to depict the location of the distal end of the deflecting guide catheter on a real-time display map of the heart.
- a magnetic based location sensor such as those manufactured by Biosense Webster for sensing the location and orientation (six degrees of freedom) of the distal end of the deflecting guide catheter and for providing location information that may be registered with other preaquired or real-time images or otherwise used to depict the location of the distal end of the deflecting guide catheter on a real-time display map of the heart.
- Systems such as the Carto® system produced by Biosense Webster would be useful for this purpose.
- FIG. 12 is an elevational view of a plication device 400 for use in the method of treating mitral valve regurgitation in accordance with the present invention.
- Plication device 400 is comprised of a handle assembly 410 and a distal assembly 450 having an elongate shaft 452 at the distal end of which are attached a plication assembly with an end effector 520 .
- FIG. 13 is an elevational view of the internal components of the handle assembly 410 .
- Handle assembly 410 is comprised of two polycarbonate shell portions—right handle shell 412 and left handle shell 414 that are adapted to house the internal components of the handle assembly.
- Internal to handle assembly 410 reside crank assembly 420 for advancing a retainer stored in the distal portion of the elongate shaft 452 .
- the firing assembly 420 is comprised of counter gear 421 , drive gear assembly 422 , idle gear 423 , and crown gear 424 . Firing assembly 420 is coupled to the firing knob 430 , shown in FIG. 12 , which is rotatably coupled to left handle shell 414 . While not shown, a second firing knob can be disposed on the opposed side of the handle assembly 410 to allow a user to selectively rotate either knob. Either firing knob further comprises a anti-backup leaf spring (not shown) that prevents the knob from turning in the reverse direction and a trigger lockout spring (not shown) that prevents the knob from turning until the trigger is fully closed or engaged. Continuing to refer to refer to FIG.
- the gears 421 , 422 , 423 and 424 of firing assembly 420 are configured to rotate in response to rotation of the firing knob 430 .
- the gears communicate with one another to cause corresponding rotation of pinion assembly 437 and drive shaft 436 .
- Drive shaft 436 is mated to a proximal end of firing control wire 490 .
- End cap 460 has a plurality of ridges dispersed around it circumference to aid the grip of the user.
- the trigger 416 is pivotally mounted within the handle assembly 410 by a pivot pin 417 , and includes a distal portion having a thumb grip formed therein and a proximal extension arm 418 .
- the trigger 416 also includes a latch 419 a that is adapted to be received in the latch receiver 419 b in the handle assembly to lock the trigger into a closed position.
- the extension arm 418 is coupled to a shuttle assembly 440 that moves between proximal and distal positions within the housing assembly 410 .
- the shuttle assembly 440 can have various configurations and it can include various features, such as an overload mechanism. The particular configuration of the shuttle assembly 440 is described in more detail in U.S. Patent Publication No. 2005/0277954 herein incorporated by reference.
- FIGS. 14A and 14B Some of the internal parts of the shuttle assembly 440 including spring pin 446 , force limiting spring 442 , spring caps 444 a and 444 b are shown in FIGS. 14A and 14B .
- the shuttle assembly 440 is coupled to a proximal portion of end-effector control wire 510 , which extends through the elongate shaft 452 .
- the distal end of the end effector control wire 510 mates (preferably by welding) to wire connector 542 , which is shown in FIG. 14D
- the wire connector 542 is positioned as shown in FIG. 14G proximal to the end effector 520 , i.e., the clevis 522 and jaws 524 a and 524 b .
- Wire connector 542 is also welded to two parallel pull wires 544 a and 544 b that run from wire connector 542 through nut 550 and terminate in holes at the proximal end of jaws 524 a and 524 b respectively.
- wire connector 542 splits the force of end effector control wire 510 into two forces for controlling the opening and closing of the jaws.
- Other arrangements are possible if, for example, it would be desired to have one fixed jaw and one movable jaw rather than two movable jaws. It is also possible to have some passive articulation of the distal jaws 524 a and 524 b by having the pull wires 544 a and 544 b pass through wire connector 542 as depicted in FIG.
- Distal jaws 524 a and 524 b rotate around pivot point rivots 523 a and 523 b respectively.
- the firing control wire 490 extends through the elongate shaft 452 and through a bore formed in the wire connector 542 and is threadably mated to a threaded bore in nut 550 .
- the distal end of the firing control wire 490 extends into a retainer pusher 554 set in a retainer pusher sleeve 556 , both of which are shown in FIG. 14E and which is described in more detail in US. Publication No. 2005/0277954.
- rotation of the firing knob 430 is effective to rotate the firing control wire 490 .
- the firing control wire 490 is threadably mated to the nut 550 , which is fixed between the proximal and distal portions of the elongate shaft 452 , the threaded bore in nut 550 will cause the firing control wire 490 to move distally through the elongate shaft 452 , thereby advancing the retainer pusher 554 in a distal direction.
- the retainer pusher 554 is positioned proximal to one or more retainers 500 stored within a garage 532 in the distal portion of the elongate shaft 452 , and thus distal movement of the pusher 554 will advance the retainers 550 through the shaft 452 to position the distal most retainer within the jaws 524 a and 524 b of the end effector 520 .
- a person skilled in the art will appreciate that a variety of other techniques can be used to advance a plurality of retainers through the elongate shaft and to position a retainer within the jaws.
- the coil connector 512 which is made of a metal, preferably brass, and is used as a means for connecting the proximal portion 452 a of elongate shaft 452 to the handle assembly.
- Dual lumen inner sheath 560 has lumens for end-effector control wire 510 and firing control wire 490 .
- Filler tube connector 562 is used to connect the coil connector 512 to the elongate shaft 452 and is glued to coil connector 512 and elongate shaft 452 using an adhesive glue such as cyanoacrylate.
- Elongate shaft 452 is broken into proximal shaft section 452 a and distal shaft section 452 b .
- Proximal shaft section 452 a is preferably nitinol and has a dovetail laser pattern.
- Distal shaft section 452 b is preferably stainless steel and has a similar dovetail pattern cut through the wall of the shaft. Other patterns could also be used such as a helical cut as shown in FIG. 16A .
- FIG. 16B depicts another variation of the plication device where the proximal shaft section is similar to that above but the nut is placed significantly more distally and the stainless steel distal shaft section with a dovetail pattern is replaced with a helical cut creating a ribbon coil.
- FIG. 16C depicts the placement of the nut and the dovetail patterns of the proximal and distal shaft portions discussed with respect to FIGS. 14A-F above.
- FIG. 16D depicts the passively articulating jaws of the alternative embodiment discussed above.
- Retainer 500 is comprised of stainless steel or other biocompatible material such as MP35N, platinum, nitinol and cobalt chromium or alloys thereof.
- the helical retainer may also be made of a or polymeric material such as one made of poly lactic acid (PLA) and/or poly glycolic acid (PGA).
- the retainer is comprised of a metal alloy with the preferred embodiment containing at least a trace of an element having an atomic number greater than 53 such as platinum to enhance visibility of the retainer under fluoroscopy. Additionally, a sufficient wall thickness should be chosen to ensure visibility under fluoro.
- the shape of the tip of the distal jaws of the plication device also have an alignment feature when viewed under fluoro that allows the viewer to determine which of 2 orientations (0/180 or 90/270) the jaws are in. In a 0/180 orientation the tip of the jaws form a circle as depicted in FIG. 14F . In a 90/270 orientation the tip of the jaws form a minus as depicted in FIG. 14B .
- the retainer 500 is preferably “C” shaped with elongated legs which may vary in length depending on the depth of tissue to be penetrated and the number of retainers that are desired to be housed within the garage of the plication device.
- the tips 501 are designed to be folded by the distal tips of the jaws of the end effector during the process of advancement to prevent the retainer from backing out or being pulled out of the plicated tissue.
- the retainer could be coated with one or more pharmacologically active agents such as heparin for the purpose of reducing thrombotic potential.
- the plication device may further comprise a magnetic based location sensor such as those manufactured by Biosense Webster for sensing the location and orientation (six degrees of freedom, x, y, z, roll (Xrot), pitch (Yrot) and yaw (Zrot)) of the distal end of the deflecting guide catheter and for providing location information that may be registered with other preaquired or real-time images or otherwise used to depict the location of the distal end of the deflecting guide catheter on a real-time display map of the heart.
- Systems such as the Carto® system produced by Biosense Webster would be useful for this purpose.
- the incorporation of the magnetic based location sensor near the distal tip of the plication device enables precise orientation of the jaws in order to facilitate placement of the jaws and plication of the tissue.
- the magnetic location sensors would be placed proximal the distal end of the jaws of the plication device due to shielding if such sensors were placed in the jaws themselves.
- Location information is then transmitted through electrical conductors to circuitry in the handle of the plication device which is electrically connected to a Carto® mapping system.
- the Carto® mapping system will then use the location information from the magnetic location sensors in order to extrapolate the location and layout of the distal end of the plication device.
- a sensor should also be placed in the handle of the plication device that would provide a signal to the Carto® system indicative of the open/closed position of the jaws. With this information the Carto® system will be able to display a real-time image of the heart and the location of the distal end of the plication device within the left ventricle, etc.
- the devices disclosed herein can also be designed to be disposed of after a single use, or they can be designed to be used multiple times. In either case, however, the device can be reconditioned for reuse after at least one use. Reconditioning can include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly.
- the device can be disassembled, and any number of the particular pieces or parts of the device can be selectively replaced or removed in any combination.
- the device can be reassembled for subsequent use either at a reconditioning facility, or by a surgical team immediately prior to a surgical procedure.
- reconditioning of a device can utilize a variety of techniques for disassembly, cleaning and/or replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Surgical Instruments (AREA)
- Prostheses (AREA)
Abstract
A system and method for the treatment of mitral valve regurgitation by reshaping the mitral valve annulus using one or more plications of annular or adjacent tissue each fixed by a retainer is described. The system includes four devices to achieve such percutaneous direct plication annuloplasty. The first is a crossing catheter having a prolapseable or curved tip. Second, a deflecting guide catheter is used to provide a means for guiding the plication device into proper position at the subvalvular region of the mitral valve annulus. Third, the plication device is then used to make plications in the subvalvular region of the mitral valve annulus. Fourth, a “C” shaped retainer with deformable ends is deployed by the plication device in order to retain the plicated tissue in the plicated form.
Description
- This application is a divisional of U.S. application Ser. No. 12/249,388 filed on Oct. 10, 2008, which claims the benefit of U.S. Provisional Patent Application No. 60/981,303 filed Oct. 19, 2007, which are hereby incorporated by reference in its entirety.
- The present invention relates to a device and method for treating the vasculature and internal organs of a patient. Particularly, the present invention is directed to a system and method for treating mitral valve regurgitation in the heart of a patient using direct plication annuloplasty.
- Catheter based devices are used to treat a wide variety of medical problems in a minimally invasive manner. Catheters are used to place and expand angioplasty balloons used to widen veins and arteries narrowed by plaque. Small scaffolds called stents have been introduced into the vasculature using catheter-based systems in order to prevent the restenosis of such vessels. One of the problems that a catheter based device and system could be used to treat in a minimally invasive manner is mitral valve regurgitation, however, no commercially successful device for the treatment of mitral valve regurgitation in such a manner currently exists.
- Mitral valve regurgitation is the backflow of blood from the left ventricle into the left atrium due to an improper alignment of the leaflets of the mitral valve thereby causing an imperfect closure of the valve. A gap between the anterior leaflet and posterior leaflet of the mitral valve is created by the improper closure providing a conduit for blood to flow through the mitral valve in a retrograde manner from the left ventricle to the left atrium. This gap may be a congenital defect or may be caused by disease, i.e., ischemic or idiopathic cardiomyopathy and/or intrinsic degenerative disease of components of the mitral valve apparatus. One type of condition, congestive heart failure (CHF), causes the heart to enlarge. In an enlarged heart the walls of the left ventricle are expanded or dilated which causes the papillary muscles to be displaced downward and/or outward resulting in a tethering of the chordae tendineae and subsequent tethering/pulling on the leaflets. Also, with CHF, the mitral annulus is dilated. The combination of the dilated annulus and the tethering on the leaflets prevents the leaflets from closing properly, thereby causing the problematic gap in the mitral valve. The resultant backflow through the mitral valve reduces the efficiency of the heart resulting in a need for the heart to beat faster and/or more forcefully in order to produce the same amount of blood flow. Mitral valve regurgitation may be asymptomatic in some patients but in other patients the reduction in blood flow and the resultant strain on the heart could result in arrhythmias, heart attack and possibly death.
- The preferred current treatments for mitral valve regurgitation require open-heart surgery and/or the use of endoscopic techniques that are difficult for the surgeon and potentially dangerous for the patient. In one method of treatment, porcine heart valves or mechanical heart valves are used to replace the damaged or defective mitral valve. Such treatments require the use of open-heart surgery to accomplish the implantation. Such heterologous valves may be used in humans but often wear-out prematurely and additional open-heart surgery is required to replace such valves with additional heterologous or mechanical valves. Mechanical valves have been developed which may also be used as a replacement for a defective mitral valve, however, the implantation of a mechanical valve usually indicates long-term anti-coagulant therapy to prevent clots from developing around the valve that could lead to a dangerous embolism. Long-term anticoagulant treatment causes other problems such as unwanted internal and external bleeding and possibly strokes.
- Another open-heart surgical procedure for treating functional mitral valve regurgitation is annuloplasty. In an annuloplasty procedure, a generally “D” shaped annuloplasty ring is implanted on the mitral valve annulus to reduce the size of the stretched mitral valve annulus, most importantly, the septal-lateral dimension and improve closing (or coaptation) of the valve thereby reducing regurgitation. The surgeon surgically attaches, i.e., sews, the annuloplasty ring to the mitral valve on the atrial side of the mitral valve. The annuloplasty ring is sewn to the annulus on a top portion (i.e., the atrial side) of the mitral valve. Once implanted, tissue generally grows over the annuloplasty ring, and a line of contact between the annuloplasty ring and the mitral valve will essentially enable the mitral valve to appear and function as a normal mitral valve by reestablishing coaptation of the mitral valve leaflets but the durability of the effect is variable and may decline within six months after the procedure. Although a patient who receives the annuloplasty ring may be subjected to anti-coagulant therapies, the therapies are not extensive, as a patient is only subjected to the therapies for a matter of weeks, e.g., until tissue grows over the annuloplasty ring.
- A second open-heart surgical procedure used in the treatment of degenerative mitral valve regurgitation is the Alfieri stitch procedure which the uses an edge-to-edge suture in the mitral valve. An edge-to-edge stitch is used to stitch together an area at approximately the center of a gap defined between the anterior and posterior leaflets of the mitral valve. Once the stitch is in place, the stitch is pulled in to form a suture that holds the anterior leaflet against the posterior leaflet. By reducing the size of the gap between the anterior leaflet and the posterior leaflet, the amount of leakage through the mitral valve may be substantially reduced. Durability has been a concern for Alfieri procedures done without the addition of an annuloplasty ring. In addition, use of the edge-to-edge procedure is only indicated in certain degenerative pathologies where the primary abnormality or gap between the leaflets is centrally located.
- Another method of treating mitral valve regurgitation is the implantation of a ventricular assist device. Such devices are expensive and difficult to implant and require the patient to use anti-coagulant therapy indefinitely. Long-term use of anti-coagulant therapy may result in unnecessary bleeding and strokes. Such ventricular assist devices are, therefore, indicated for use only in patients that would likely not survive without their use and are used to keep patients alive who are candidates for heart transplant surgery. Left ventricular assist devices are a “bridge” therapy rather than a final therapy.
- While such invasive surgical procedures have under certain circumstances been shown to be effective in the treatment of mitral valve leakage, invasive surgical procedures often have significant drawbacks. Any time a patient undergoes open-heart surgery, there is a risk of infection. Opening the sternum and using a cardiopulmonary bypass machine has also been shown to result in a significant incidence of both short and long term neurological deficits.
- Some minimally invasive procedures have been developed to treat mitral valve regurgitation but, to date, none have become commercially successful standard procedures. U.S. Pat. No. 6,619,291 to Hvlaka et al. discloses a minimally invasive method of performing annuloplasty including inserting an implant into a left ventricle and orienting the implant in the left ventricle substantially below the mitral valve. The implant and tissue around the mitral valve are connected and tension is provided to the implant in order to substantially reduce an arc length associated with the mitral valve.
- In U.S. Pat. Nos. 6,718,985 and 7,037,334 to Hvalaka et al. a series of plications near the mitral valve are created by T-bars that are threaded together to reshape the mitral valve. In U.S. Pat. No. 7,166,127 a catheter based system for treatment of mitral valve regurgitation uses a retainers adapted to be secured to the annulus of the mitral valve with flexible tensile members coupled to the retainers. A crimping device deployable through the catheter compresses a crimp onto the flexible tensile members after they are pulled toward one another to reduce the circumferential length of the annulus. In this system the number of permanent implants required in order to achieve an initial effect, and commitment to these implants before success of effect is able to be determined are serious drawbacks.
- In United States Patent Application Publication No. 2007/0093857, Rogers et al. describes a device and method for the treatment of mitral valve regurgitation using a minimally invasive procedure in which plications are made proximate the mitral valve of the patient and a retainer is placed to hold the plication.
- United States Patent Application No. 2007/0032797 discloses a device for reducing the size of the stomach having a corkscrew-shaped anchor for placement in the gastric wall.
- United States Patent Application No. 2007/0025737 to Messerly et al. discloses a surgical retainer having a generally helical shape and a device having jaws for grasping tissue into which the helical retainer may be driven.
- United States Patent Application No. 2007/0055335 discloses an electrode probe having a corkscrew-shaped distal tip for use in cardiology applications.
- The need remains for a device and method for treating mitral valve regurgitation that can be used efficiently and effectively in a minimally invasive procedure and that provides the physician with the ability to know that the procedure has resulted in the desired effect prior to removing the device from the patient thereby reducing the need for and expense of repeat procedures. Such a procedure should provide the physician with the ability to changes the effect on the mitral valve during the procedure before taking an irreversible action.
- The present invention provides a system and method for the treatment of mitral valve regurgitation. The method preferably uses a femoral retrograde approach of crossing the aortic valve. Access to the left ventricle is achieved through the aortic valve using the standard retrograde femoral artery approach utilizing a rounded crossing catheter (CC) preferably with a “J” or pigtail configuration. A deflecting guide catheter is then sent over the crossing catheter into the left ventricle. When the distal end of the deflectable catheter is in the left ventricle the crossing catheter is removed. The deflectable guide is preferably, but need not be, positioned between the papillary muscles with the distal segment lying along the posterior wall of the left ventricle and its tip is pointing towards the underside of the posterior mitral valve annulus. A plication device is then introduced through the deflectable catheter and is advanced out of the distal end of the deflectable catheter and is directed at the underside of the mitral valve, more preferably into the subvalvular groove and positioned so as to be able to grasp and plicate the tissue of the mitral valve at or near the annulus.
- A test plication of the mitral valve annulus is created and the appropriateness of the plication is examined using imaging means such as TEE, ICE, TTE or fluoroscopy with or without contrast injection. If the plication is determined to be appropriate then a retainer is applied to the plication to retain the tissue in the plicated state. If the plication is not satisfactory then a retainer is not applied and the jaws of the plication device are released and the plicator is repositioned to plicate a different tissue target at or near the annulus of the mitral valve. Such “test” plications may be repeated a number of times prior to deploying the retainer.
- If a single plication and retainer do not sufficiently reshape the mitral valve to correct the regurgitation then the original deflectable guide is repositioned and a second plicator with a retainer is introduced into the delivery guide and positioned and used in the same manner. Alternatively, a multi-retainer plicator can be used to provide the second or third retainers as necessary during the procedure without requiring the removal and reintroduction of the plication device. Once satisfactory changes in the annular geometry of the mitral valve and concomitant reduction in mitral valve regurgitation is achieved then the plication device and the deflectable guide are fully withdrawn and the femoral access site is closed using conventional closing techniques.
- Four components comprise the system for percutaneous direct plication annuloplasty. The first is a prolapsable or curved tip crossing catheter preferably having a “J” or pigtail configuration. This may be used with or without a guidewire. In either case the crossing catheter is inserted in a stack or telescoped configuration with the second component, a deflecting guide catheter within which the crossing catheter is initially telescoped or stacked. The deflecting guide catheter is used to provide a means for guiding the plication device into proper position on the underside of the mitral valve preferably at the subvalvular region of the mitral valve at or near the annulus. The third component of the system is a plication device that has an end effector having opposing members at least one of which can be manipulated to open. The plication device is used to grasp tissue and also contains at least one retainer to retain the tissue in the plicated form if desired. The retainer in the preferred embodiment is a “C” shaped retainer having an end portion and two substantially perpendicular prongs that are pushed into the plicated tissue. The ends of the prongs may be compressed to increase the pressure on the plicated tissue and to prevent the retainer from being dislodged from the plicated tissue.
- The present invention is a method for the percutaneous treatment of mitral valve regurgitation by reshaping a mitral valve annulus through an arterial access site in a patient comprising the steps of inserting a crossing catheter and a deflecting guide catheter having a lumen therethrough ending in a distal opening into the arterial access site of the patient; advancing the crossing catheter through the aortic valve into the left ventricle; advancing the deflecting guide catheter over the crossing catheter through the aortic valve into the left ventricle; withdrawing the crossing catheter from the patient; positioning the deflectable guide catheter with the distal opening pointing towards the underside of the mitral valve annulus; introducing a plication device into the arterial access site through the lumen of the deflectable guide catheter and advancing the plication device out the distal opening of the deflectable guide catheter; positioning the plication device at a first position in on the underside of the mitral valve at or near the annulus; plicating a first portion of tissue of the mitral valve using the plication device to create a first tissue plication; and applying a retainer to the first tissue plication.
- Additionally the method can include the steps of examining the first tissue plication using an imaging method to produce an image of the mitral valve; and, determining if the plication is acceptable prior to the step of applying the retainer. Furthermore, the method can include the steps of: releasing the plication if the plication is determined not to be appropriate at the examining step; repositioning the plication device at a second position in the subvalvular groove of the mitral valve annulus; and plicating a first portion of tissue of the mitral valve at or near the annulus using the plication device to create a first tissue plication. The method may also include the steps of: determining if the first tissue plication as retained by the retainer sufficiently reshapes the mitral valve annulus to treat the mitral valve regurgitation; repositioning the deflectable guide catheter to a second position on the underside of the mitral valve at or near the annulus; introducing a second plication device or using a reloaded multi-retainer plication device in the delivery guide catheter and positioning the second plication device in the subvalvular region of the mitral valve; plicating a second portion of tissue of the mitral valve at or near the annulus using the plication device to create a second tissue plication; and; applying a retainer to the second tissue plication. Finally, the method may include the steps of withdrawing the deflectable guide catheter and the plication device and closing the arterial access site.
- The present invention is directed to a system for the treatment of mitral valve regurgitation through direct plication annuloplasty of a patient that includes a deflecting guide catheter having an elongate body with lumen therethrough ending in a distal opening for insertion through the aortic valve into the left ventricle of the patient, a plication device having a set of opposing jaws operable to plicate tissue in the mitral valve of the patient, wherein the plication device comprises at least one retainer for retaining plications in tissue. Optionally, the system includes a crossing catheter having a distal end for insertion through the aortic valve into the left ventricle of the patient. The crossing catheter may be J-shaped or pigtail shaped. The system may also include a guidewire for use in guiding the crossing catheter through the vasculature of the patient and into the left ventricle. The retainer is preferably “c” shaped and comprises two prongs having ends connected by an intermediate member.
- The present invention also includes a method for the percutaneous treatment of mitral valve regurgitation by reshaping a mitral valve annulus through a venous access site in a patient including the steps of accessing the right atrium through the venous access site with a transseptal access catheter; puncturing the septum using the transseptal access catheter; advancing the deflecting guide catheter over the transseptal access catheter through the transseptal puncture into the left atrium; withdrawing the transseptal access catheter from the patient; positioning the deflectable guide catheter with the distal opening pointing toward the mitral valve annulus; introducing a plication device into the venous access site through the lumen of the deflectable guide catheter and advancing the plication device out the distal opening of the deflectable guide catheter; positioning the plication device at a first position at or near the annulus of the mitral valve in the left atrium; plicating a first portion of tissue of the mitral valve using the plication device to create a first tissue plication; and applying a retainer to the first tissue plication.
- The transseptal method may further include the steps of examining the first tissue plication using an imaging method to produce an image of the mitral valve; and, determining if the plication is acceptable prior to the step of applying the retainer; releasing the plication if the plication is determined not to be appropriate at the examining step; repositioning the plication device at a second position at or near the mitral valve annulus; plicating a first portion of tissue of the mitral valve at or near the annulus using the plication device to create a first tissue plication; determining if the first tissue plication as retained by the retainer sufficiently reshapes the mitral valve annulus to treat the mitral valve regurgitation; repositioning the deflectable guide catheter to a second position at or near the mitral valve annulus; introducing a second plication device or using a reloaded multi-retainer plication device in the delivery guide catheter and positioning the second plication device at or near the mitral valve annulus; plicating a second portion of tissue of the mitral valve at or near the annulus using the plication device to create a second tissue plication; and; applying a retainer to the second tissue plication. The method concludes with the withdrawal of the deflectable guide catheter and the plication device and closing the venous access site.
-
FIGS. 1A and 1B are a flow diagram describing the method of treating mitral valve regurgitation in accordance with the present invention. -
FIGS. 2A-H depict the stages of the various steps of the method of treating mitral valve regurgitation in accordance with the present invention. -
FIG. 3 depicts the plication regions in the method of treating mitral valve regurgitation in accordance with the present invention. -
FIG. 4 is a perspective view of a crossing catheter for use in treating mitral valve regurgitation in accordance with the present invention. -
FIG. 5 is a cutaway view of a portion of the body of the crossing catheter ofFIG. 4 . -
FIG. 6 is an elevational view of a deflecting guide catheter for use in treating mitral valve regurgitation in accordance with the present invention. -
FIGS. 7A and 7B are an exploded view and a perspective view respectively of the components of a handle for the deflecting guide catheter ofFIG. 6 . -
FIG. 8 is an elevational view of the body portion of the deflecting guide catheter ofFIG. 6 . -
FIGS. 9A and 9B are cross-sectional views of the body portion of the deflecting guide catheter ofFIG. 8 taken through lines A and B respectively. -
FIGS. 10A-10C are perspective views of the body portion of other embodiments of a deflecting guide catheter for use in treating mitral valve regurgitation -
FIG. 11 is an exploded perspective view of another embodiment of the handle and internal components used in a deflecting guide catheter in accordance with the present invention. -
FIG. 12 is an elevational view of a plication device for use in treating mitral valve regurgitation in accordance with the present invention. -
FIG. 13 is an elevational view of the plication device ofFIG. 12 with a portion removed to expose the internal components. -
FIG. 14A is an elevational view of the plication device ofFIGS. 12 and 13 from the shuttle assembly to the distal end. -
FIG. 14B is a cross sectional view of the portion of the plication device ofFIG. 14A taken through line A-A. -
FIG. 14C is an enlarged view of proximal end section D of the cross-sectional view of the portion of the plication device ofFIG. 14B . -
FIG. 14D is an enlarged view of distal section C of the cross-sectional view of the portion of the plication device ofFIG. 14B . -
FIG. 14E is an enlarged view of the distal tip section B of the cross-sectional view of the portion of the plication device ofFIG. 14B . -
FIG. 14F is an enlarged planar view of the distal tip of the plication device ofFIG. 14A . -
FIG. 14G is a detailed perspective view depicting the coupling of the end-effector control wire to the distal puller wires. -
FIG. 14 H is a detailed perspective view depicting the coupling of the end-effector control wire to the distal puller wires in an embodiment of the plication device having passive articulation. -
FIG. 15 is a perspective view of a retainer for use in a plication device for use in the treatment of mitral valve regurgitation in accordance with the present invention. -
FIGS. 16A-16D are elevational views of the distal end of various embodiments of a plication device in accordance with the present invention. -
FIG. 1 is a flow diagram depicting a method of providing direct plication annuloplasty to the mitral valve in a heart such as that depicted inFIG. 2A in accordance with the present invention. Atstep 100 the procedure begins with a puncture for access to the femoral artery using standard techniques. Atstep 102 the physician or other practitioner places a catheter sheath introducer (CSI) into the femoral access point using standard techniques. Any known CSI may be used in the procedure with the preferable size being approximately 14 french. At step 104 a crossing catheter, preferably prolapseable or having a curved tip, and a deflecting guide catheter are inserted together in a “stack” formation through the CSI. Alternatively, the deflecting guide catheter is inserted through the CSI without a crossing catheter although the use of a crossing catheter is the preferred method. The crossing catheter is described herein in greater detail with respect toFIGS. 4 and 5 below and the deflecting guide catheter is described herein in greater detail with respect toFIGS. 6 to 11 . The stacked crossing catheter and deflecting guide catheter are advanced through the arterial system of the patient traversing the aorta of the patient in a retrograde manner atstep 106. Atstep 108 the aortic valve (AV) is crossed with the crossing catheter and the crossing catheter is advanced into the left ventricle (LV) as depicted inFIG. 2B . Atstep 110 the deflecting guide catheter is advanced over the crossing catheter through the aortic valve and into the left ventricle as depicted inFIG. 2C . The deflecting guide catheter is deflected in a somewhat retroflexed manner as it is advanced approximately toward the mitral valve atstep 112 as depicted inFIG. 2D and the crossing catheter is withdrawn atstep 114. - A guidewire may also be used with the crossing catheter and deflecting guide catheter in a three-element stack inserted in the CSI. If a guidewire is used it is advanced first through the arterial system and over the aortic arch followed by the combined stack of the crossing catheter and the deflecting guide catheter. The guidewire is introduced first through the aortic valve followed by the crossing catheter which is preferably oriented into a position between the papillary muscles although this is not necessary. The procedure then continues as in
steps step 114. - Whether or not a guidewire has been used, the procedure continues with
step 116 where a region of the deflecting guide catheter is seated toward the mitral valve in the apex of the left ventricle as inFIG. 2E . Atstep 118, the tip of the deflecting guide catheter is advanced up the posterior wall of the left ventricle to a position under the mitral valve, preferably initially placed in the subvalvular groove in the P2 region of the as shown inFIG. 3 . The term “annulus” is meant to include regions at or near the annulus. Atstep 120 the position of the tip of the deflecting guide catheter is confirmed by using an imaging method such as fluoroscopy. If fluoroscopy is used one view maybe sufficient but it is preferable in most cases to use two views to confirm proper placement of the deflecting guide catheter in the P2 region of the mitral valve annulus. P2 is the likely target region for a first retainer although depending on the geometry of the mitral valve the first retainer may be placed in region P1 or region P3. Additional retainers may need to be placed in the same or other regions. - At step 122 a
plication device 400 loaded with one or more retainers is inserted into the deflecting guide catheter and advanced to the tip of the deflecting guide catheter. A plication device for use in this method is described in greater detail herein with respect toFIGS. 12 through 14H . Atstep 124 the rotational orientation of the jaws of the plication device is determined using an imaging method and the jaws are placed in the correct orientation. The preferable rotational orientation for the jaws of the plication device is such that both tips of the jaws once opened would represent a “chord” of the arc defined by the mitral valve annulus when pushed into contact with the annulus. Next, atstep 126 the plication device is advanced out of the end of the deflecting guide catheter into position under the annulus of the mitral valve as depicted inFIG. 2E . The orientation and position of the plication device is reconfirmed atstep 128 using an imaging method. Again, if fluoroscopy is used as the imaging method, at least one and preferably two views are be used to confirm orientation and placement of the jaws of the plication device. An injection of a known contrast agent either using a separate contrast catheter or through the deflecting guide catheter may be used to help define the line of the annulus as viewed under fluoroscopy. At step 130 a decision is made by the physician whether or not the jaws of the plication device are properly positioned. If the plication device is not correctly positioned then atstep 134 an attempt is made to reposition the jaws of the plication device. Atstep 136 the position of the plication device is evaluated again using an imaging method as described previously and in more detail below. If the plication device is positioned correctly then step 132 and onward are performed as discussed below. If the plication device is not positioned properly after at least one attempt at repositioning atstep 134 then step 138 results in a determination that the plication device cannot achieve a desired position and the plication device and deflectable guide catheter are withdrawn from the patient atstep 150. - If the jaws are properly positioned, a diagnostic clamp or plication is performed at
step 132. As part of the diagnostic clamping (or plication), the jaws of the plication device are opened as depicted inFIG. 2F , the plication device is advanced onto the tissue of the annulus of the mitral valve and the jaws are closed as depicted inFIG. 2G . The diagnostic plication is evaluated atsteps step 140 and the plication device is released as depicted inFIG. 2H . Embodiments of a retainer that may be applied to the tissue are described in greater detail herein with respect toFIG. 15 . Atstep 142, if the diagnostic plication results in an unacceptable change to the mitral valve then the procedure is abandoned and both the plication device and the deflectable guide catheter are withdrawn from the patient atstep 150. Atstep 144, if the diagnostic plication results in an insufficient or inadequate reduction in mitral valve regurgitation (MR) and/or insufficient or inadequate change in the mitral valve then the diagnostic plication is released and an attempt to reposition the jaws of the plication device is performed atstep 134. - If the change to the mitral valve is acceptable and a retainer has been applied, then at step 145 a determination regarding the impact of the plication on the regurgitation of the mitral valve is made using a method of imaging the flow of blood through the valve such as Doppler echocardiograpy. At
steps step 146, if the determination is made that there has been an acceptable total reduction in mitral valve regurgitation and/or acceptable change in the mitral valve then the procedure branches to step 150 with the retrieval of the plication device and the deflecting guide catheter. If the total change to mitral valve regurgitation is inadequate or insufficient and/or change to the mitral valve is inadequate or insufficient (step 147) then the plication device currently in use is withdrawn if it is a single retainer device and an additional plication device is inserted and the procedure continues fromstep 122. If the plication device is a multi-retainer device then the procedure continues fromstep 124 without withdrawal of the plication device. If the determination regarding the impact of the plication on mitral valve regurgitation results in a finding of an adverse result atstep 148 then the procedure will likely be abandoned and both the plication device and deflecting guide catheter are removed from the patient atstep 150. After removal of the plication device and the deflecting guide catheter, the catheter sheath introducer is removed and the access site is closed atstep 152 using known methods. - In the above method various imaging modalities may be used to determine proper placement of the plication device under the mitral valve annulus. Fluoroscopy is one real-time imaging modality that is useful, preferably, where images are taken in at least two planes. Radiopaque markers placed on the distal end of the plication device and/or deflecting guide will aid in determining proper placement. A three-dimensional profile of the plication device can be created using x-ray images acquired in at least two planar projections in real-time. Alternatively, rotational angiographic imaging may be used. Additionally, registering pre-acquired CT or MRI image data with the fluoroscopic image will provide additional anatomic data to the physician to aid proper placement of the plication device and retainer or retainer. Similarly, a three-dimensional real-time ultrasound image acquired in real-time may be registered with the fluoroscopic image.
- Another imaging modality useful for this purpose is intracardiac echocardiography (ICE) used to produce an ICE image. The ICE image may be produced by an ICE catheter placed inside one of the chambers of the heart such as the right ventricle, left ventricle, left atrium or the right atrium. Alternatively, the ICE catheter could be placed inside on of the great vessels of the heart of the patient. The ICE catheter may also be placed on the epicardial or pericardial sack surfaces of the heart via a minimally invasive approach such as a sub-xiphoid approach.
- No matter the modality used, the images of the mitral valve should be taken synchronized to the cardiac cycle.
- Various imaging modalities are also useful in determining whether the plication achieves the desired impact on the function of the mitral valve in real-time or near real-time prior to applying the retainer to the plication. Real-time means that the latency period is acceptable to perform the procedure and is preferably no more than 500 milliseconds. Color Doppler ultrasound imaging may be used for such a purpose with or without an ultrasound contrast agent being administered to the patient. Alternatively, x-ray fluoroscopy could be used in determining the impact of a plication on mitral valve regurgitation by using an x-ray contrast bolus injection into one of the chambers of the heart, preferably the left ventricle. Bi-planar angiographic imaging or intra-chamber optical imaging may also be used. If intra-chamber optical imaging is used it is preferable that the deflecting guide catheter further comprise an optical imaging system particularly one that operates in infrared wavelengths.
- Determining a location for the first tissue plication may be based on an optimization plan generated using a three-dimensional functional numerical simulation based on imaging data generated by one or more of the aforementioned imaging method. For example, by analyzing the distribution of annular tissue relative to the location of the primary regurgitant flow through the valve, a primary target for initial plication therapy may be determined. It may be desirable to place the plication at the location of greatest distortion of the annulus due to the pathology of the patient's heart. The generation of the optimization plan may be performed prior to step of inserting the crossing catheter. The generation of the optimization plan may be performed after the step of applying a retainer to the first tissue plication in order to determine the preferred location for subsequent plication or plications.
- Alternatively, the plications could be made on the atrial surface if a transseptal approach is used. This can be accomplished by accessing the right atrium using SVC or IVC venous approaches. Then access the left atrium is accomplished using a standard transseptal puncture/access kit such as a Brockenbrough transseptal needle kit. The deflecting guide catheter would then be introduced through the puncture and deflected such that the tip pointed towards the annulus of the mitral valve. The subsequent steps and devices for a plication annuloplasty procedure would then be the substantially the same as set forth above except that the approach is from the atrial side of the mitral valve rather than the underside.
- The above method is implemented using a multi-component system comprising a crossing
catheter 200, a deflectingguide catheter 300, and aplication device 400 containing at least oneplication retainer 500.FIG. 4 is a perspective view of a crossingcatheter 200 for use in the procedure described in the present application. Crossingcatheter 200 is comprised of abody portion 210 having aproximal end 210 a and adistal end 210 b. Connected toproximal end 210 a are afemale luer lock 216 and a Tuohy-Borst hemostasis valve 214. At thedistal end 210 b portion is attached which is preferably apigtail 218 or has a “J” configuration (not shown).Pigtail 218 is approximately 2.0 centimeters or less in diameter. InFIG. 4 pigtail 218 is attached tobody portion 210 at a splice location that is approximately 4 centimeters from the distal end of the device.Pigtail 218 is attached tobody portion 210 using heat bonding as thebody portion 210 andpigtail 218 re made from the same or similar material.Pigtail 218 is comprised of a polymer, preferably, Pebax® polyether block amide having a durometer of approximately 55 D if comprised of one layer or two layers having durometers of approximately 40 D in the outer layer and 55 D in the inner layer.Body portion 210 may be comprised of one layer having a durometer between 55 D and 72 D or may have two layers. If two layers are used the preferred durometers are 70 D for the outside and 63 D for the inside. The total length of the body portion and pigtail together is approximately 149 centimeters and should extend beyond the deflecting guide catheter when fully inserted into the deflecting guide catheter thus the length of the crossing catheter may vary depending on the length of the deflecting guide catheter used. The location at which the pigtail may be attached to the body portion may also vary from 3 centimeters to approximately 44.5 centimeters from the distal tip of the crossingcatheter 200. The crossing catheter may also be comprised of one material from the body portion through the pigtail. In such a case the use of an outer material with a durometer of 55 D and an inner material with a durometer of 40 D is preferred. Aflat wire braid 212 of flat wires of approximately 0.001″ by 0.003″ may be embedded in the polymer comprising the proximal portion ofbody portion 210 in order to provide extra stiffness and torqueability. Aninner layer 211 of PTFE provide a lubricious inner coating and a separation between the polymer and the inner lumen. The stiffness of the pigtail portion of the crossing catheter is chosen so that a standard guidewire such as the Cordis Emerald 0.035″ guidewire will open up the pigtail yet will return to the pigtail shape when retracted. Such a guidewire is placed in the guidewire lumen defined by theinner layer 211 of the crossing catheter and should extend through the entire length of the crossing catheter. - Crossing
catheter 200 may be used with or without a guidewire as described above and is preferably used in conjunction with the deflecting guide catheter depicted in FIGS. 6 through 10A-C.Deflecting guide catheter 300 is comprised of ahandle 310 and abody portion 350.FIG. 7A is an exploded view of an embodiment of thehandle 310 depicting the internal components of the handle andFIG. 7B is a perspective view of the internal components ofhandle 310 as assembled. Handle 310 is comprised ofupper handle shell 312 andlower handle shell 314 which are made of a durable moldable polymeric material such as polycarbonate or other similar material and are designed to mate with one another in a snap fit arrangement. At the proximal end ofhandle 310 is ahemostasis valve 316 which is adapted to fit onto theproximal handle tip 318.Hemostasis valve 316 may be of any known design for such a valve such as a tuohy-borst type valve.Proximal actuator assembly 324 is comprised of athumb actuator 324 a that is adapted to be inserted throughslot 313 in theupper handle shell 312. Optionally, a two-piece construction with athumb cap 325 may be used to facilitate assembly ifslot 313 is narrow. Thethumb actuator 324 a andoptional thumb 325 cap are used to cause forward motion in the proximal direction ofpuller wire 327 a. Such motion is retained as the prong orprongs 324 e biased byspring 324 d around pivotpoint axel pin 324 c engages theteeth 322 a inproximal rack 322. Such proximal motion of theproximal actuator assembly 324 and the associatedpuller wire 327 a causes the deflection of the distal end of the deflectingguide catheter 300. If the user desires to have distal motion of theproximal actuator assembly 324 then the userpushers release trigger 324 b which counters the bias ofspring 324 d thereby releasing prong orprongs 324 e from engagement with theteeth 322 a of theproximal rack 322. Proximal hypotube 331 a provides a passage way forpuller wire 327 a and prevents kinking of the wire.Distal hypotube 331 b is designed to telescope inside hypotube 331 a. At the end ofpuller wire 327 a are fixedly attachedcrimp tube 334 a and a floating crimp tube stop 334 b that prevents the crimp tube from being embedded in the proximal end of the actuator assembly. The user may then move the actuator assembly distally thereby changing the deflection of the distal end of the deflecting guide catheter. Movement of the actuator assembly may be made by the physician using something other than his or her thumb and the terms “thumb actuator” and “thumb cap” are not meant to be limiting. - Handle 310 further comprises a
distal actuator assembly 328 having asimilar thumb actuator 328 a,release trigger 324 b,axel pin 324 c,spring 328 d andprong 328 e.Optional thumb cap 329 is affixed overthumb actuator 328 a. Thedistal actuator assembly 328 is connected to asecond pullerwire 327 b (shown inFIG. 11 ) that enables the user to cause deflection of the distal end of the deflecting guide catheter. In a preferred embodiment the first and second puller wires are attached (through known methods and means such as welding, brazing or adhesives) to anchorbands distal region 360 of thebody portion 350 of the deflecting guide. The puller wires and their respective anchor band connection points may also be arranged so that they are not next to one another (in an axial manner) but so that each provides motion of the distal end in another plane or in the other direction within the same plane. Also, the second puller wire and actuator are not necessary if it is only necessary to provide one type of movement in the deflecting guide catheter. Correspondingly, if greater than two types of deflection are required, additional thumb actuator assemblies coupled to puller wires and anchor bands may be added in a similar manner to the catheter. The second distal actuator assembly has the same components as functions in the same manner as the proximal actuator assembly. The primary difference is that thedistal actuator assembly 328 requires a passageway for passage of thefirst puller wire 327 a through the distal assembly which passage is aided byhypotube 331 b. Thesecond puller wire 327 b ends at the distal end with asimilar crimp tube 335 a and crimp tube stop 335 b.Nose cone 330 provides a transition between thehandle shell 312/314 and theproximal region 390 of thebody portion 350.Acuator assemblies racks Racks teeth lower handle shell 314 as depicted in the alternative embodiment shown inFIG. 11 . Handleinsert 338 is used as a divider between the tworacks Puller wires -
Puller wires anchor band -
Body portion 350 of deflectingguide catheter 300 is depicted inFIG. 8 andFIGS. 9A and 9B . Body portion is separated into four regions:distal region 360, intermediatedistal region 370, main intermediate region 380 andproximal region 390.Distal region 360 at the distal end is approximately 3.5 centimeters in length and is made of a polymeric material such as Pebax with a durometer of between 25 D and 40 D and preferably 35 D. A radiopaque material such as bismuth subcarbonate is added to the material indistal region 360 to enable thedistal region 360 of the deflectingguide catheter 300 appear in fluoroscopy and other imaging procedures. The wall thickness in thedistal region 360 is between approximately 0.012 and 0.014 inches. Theanchor band 385 a for the first puller wire is embedded near the distal end ofdistal region 360 and theanchor band 385 b for the second puller wire is embedded near the proximal end ofdistal region 360 or at the distal end ofregion 370. The anchor bands are preferable placed between thelubricious liner 365 and the braid 385 although it could be placed above the braid in an alternative embodiment. Each anchor band is made of 304 stainless steel and each puller wire is attached to its respective anchor band using welding or other means for joining metal that is known in the art. The internal diameter ofdistal region 360 as well as the entire body portion is defined by alubricious liner 365 preferably PTFE that has an interior diameter of approximately 0.127 inches and is approximately 0.002 inches thick. The outer diameter ofdistal region 360 is approximately 0.172 inches between the anchor bands and approximately 0.176 inches at the location of the distal band. Abraid 375 of wires having a diameter between 0.0025 and 0.003 inches in a 1 over 1, 1 over 2 under 2 or 2 over 2 pattern is embedded in the polymeric wall of the catheter from theproximal region 390 to thedistal region 360. At the distal end of thedistal region 360 of deflectingguide 300 is an extrudedatraumatic tip 362 comprised of 33.5% 25 D Pebax, 6.4% 55 D Pebax and 60% bismuth subcarbonate and having a slight taper toward its distal end. The atraumatic tip is optional although preferred in order to avoid tissue damage during insertion in the vessels of the patient. - Intermediate
distal region 370 is comprised of the same type of polymeric material but has a higher durometer of between 35 D and 55 D to provide a stiffer region. Intermediatedistal region 370 is between approximately 2.8 and 4.0 centimeters in length and contains the samelubricious liner 365 andwire braid 375 as the distal region. The wall thickness in the intermediate distal region is similarly between 0.012 and 0.014 inches and the outer diameter is approximately 0.172 inches. Main intermediate region 380 has a slightly smaller outer diameter at 0.166 inches but has the same lubricious liner and braid as the other regions. The main difference in this region is the higher durometer of between 55 D and 63 D for the polymeric material used in order to provide increasing stiffness. The main intermediate region is approximately 20 to 28 centimeters in length, preferably 20 centimeters.Proximal region 390 has a similar composition in that the outer diameter is the same as the immediately prior region. The durometer in this region is increased to approximately 72 D providing even greater stiffness and the length of this region is approximately 73 to 88 centimeters, preferably 88 centimeters. Thelubricious layer 365 and braid 375 are the same. - From the
proximal region 390 through thebody portion 350 until the position of first andsecond anchor bands 385 a/385 b run two wire or braid reinforcedtubes 395 a/395 b of approximately 0.0088 inches in internal diameter which house the first and second puller wires respectively. Various modifications can be made to the deflecting guide catheter if different characteristics are desired. One puller wire, anchor band and reinforced tube could be used instead of two. The braid may be changed to a different size wire and braid type. The polymeric material of the outer body may be varied as depicted inFIGS. 10A-10C . InFIG. 10A materials having two different durometers are used in an alternating fashion. Material A is used in two circumferential portions opposite one another while material B is used in two other opposing circumferential portions. The durometer of material A may be greater than the durometer of material B or vice versa depending on the deflection characteristics desired. Use of two different durometer materials in such a way provides the benefit of balancing the ability or ease of the catheters to deflect in a particular direction with the requirement for lateral stiffness. InFIG. 10B two circumferential portions of material A and material B are used to provide a certain desired deflection characteristic. InFIG. 10C the use of two different durometer materials is used in conjunction with placement of thepuller wires FIG. 10C the distal end of the deflecting guide catheter would deflect in two different planes substantially perpendicular to one another. One should note that it is not require to use two different materials or durometer types around the circumference of the outer body in order to get different planes of deflection. The plane of deflection is primarily determined by the relative placement of the puller wire lumens. - The deflecting guide catheter may further comprise a magnetic based location sensor such as those manufactured by Biosense Webster for sensing the location and orientation (six degrees of freedom) of the distal end of the deflecting guide catheter and for providing location information that may be registered with other preaquired or real-time images or otherwise used to depict the location of the distal end of the deflecting guide catheter on a real-time display map of the heart. Systems such as the Carto® system produced by Biosense Webster would be useful for this purpose.
-
FIG. 12 is an elevational view of aplication device 400 for use in the method of treating mitral valve regurgitation in accordance with the present invention.Plication device 400 is comprised of ahandle assembly 410 and adistal assembly 450 having anelongate shaft 452 at the distal end of which are attached a plication assembly with anend effector 520.FIG. 13 is an elevational view of the internal components of thehandle assembly 410.Handle assembly 410 is comprised of two polycarbonate shell portions—right handle shell 412 and lefthandle shell 414 that are adapted to house the internal components of the handle assembly. Internal to handleassembly 410 reside crankassembly 420 for advancing a retainer stored in the distal portion of theelongate shaft 452. The firingassembly 420 is comprised ofcounter gear 421,drive gear assembly 422,idle gear 423, andcrown gear 424.Firing assembly 420 is coupled to thefiring knob 430, shown inFIG. 12 , which is rotatably coupled toleft handle shell 414. While not shown, a second firing knob can be disposed on the opposed side of thehandle assembly 410 to allow a user to selectively rotate either knob. Either firing knob further comprises a anti-backup leaf spring (not shown) that prevents the knob from turning in the reverse direction and a trigger lockout spring (not shown) that prevents the knob from turning until the trigger is fully closed or engaged. Continuing to refer toFIG. 13 , thegears assembly 420 are configured to rotate in response to rotation of the firingknob 430. The gears communicate with one another to cause corresponding rotation ofpinion assembly 437 and driveshaft 436. Driveshaft 436 is mated to a proximal end of firingcontrol wire 490.End cap 460 has a plurality of ridges dispersed around it circumference to aid the grip of the user. - In
FIG. 13 , thetrigger 416 is pivotally mounted within thehandle assembly 410 by apivot pin 417, and includes a distal portion having a thumb grip formed therein and aproximal extension arm 418. Thetrigger 416 also includes alatch 419 a that is adapted to be received in thelatch receiver 419 b in the handle assembly to lock the trigger into a closed position. Theextension arm 418 is coupled to ashuttle assembly 440 that moves between proximal and distal positions within thehousing assembly 410. Theshuttle assembly 440 can have various configurations and it can include various features, such as an overload mechanism. The particular configuration of theshuttle assembly 440 is described in more detail in U.S. Patent Publication No. 2005/0277954 herein incorporated by reference. Some of the internal parts of theshuttle assembly 440 includingspring pin 446,force limiting spring 442, spring caps 444 a and 444 b are shown inFIGS. 14A and 14B . As shown inFIG. 13 , theshuttle assembly 440 is coupled to a proximal portion of end-effector control wire 510, which extends through theelongate shaft 452. The distal end of the endeffector control wire 510 mates (preferably by welding) towire connector 542, which is shown inFIG. 14D Thewire connector 542 is positioned as shown inFIG. 14G proximal to theend effector 520, i.e., theclevis 522 andjaws Wire connector 542 is also welded to twoparallel pull wires wire connector 542 throughnut 550 and terminate in holes at the proximal end ofjaws wire connector 542 splits the force of endeffector control wire 510 into two forces for controlling the opening and closing of the jaws. Other arrangements are possible if, for example, it would be desired to have one fixed jaw and one movable jaw rather than two movable jaws. It is also possible to have some passive articulation of thedistal jaws pull wires wire connector 542 as depicted inFIG. 14H and placing a plurality offerrules 549 in eachpull wire wire connector 542 proximal end of each wire so that they may translate through the wire connector thereby providing flexibility at the distal tip of the device for improved maneuverability through tortuous anatomical pathways.Distal jaws - The
firing control wire 490 extends through theelongate shaft 452 and through a bore formed in thewire connector 542 and is threadably mated to a threaded bore innut 550. The distal end of thefiring control wire 490 extends into aretainer pusher 554 set in aretainer pusher sleeve 556, both of which are shown inFIG. 14E and which is described in more detail in US. Publication No. 2005/0277954. In general, rotation of the firingknob 430 is effective to rotate thefiring control wire 490. Since thefiring control wire 490 is threadably mated to thenut 550, which is fixed between the proximal and distal portions of theelongate shaft 452, the threaded bore innut 550 will cause thefiring control wire 490 to move distally through theelongate shaft 452, thereby advancing theretainer pusher 554 in a distal direction. Theretainer pusher 554 is positioned proximal to one ormore retainers 500 stored within agarage 532 in the distal portion of theelongate shaft 452, and thus distal movement of thepusher 554 will advance theretainers 550 through theshaft 452 to position the distal most retainer within thejaws end effector 520. A person skilled in the art will appreciate that a variety of other techniques can be used to advance a plurality of retainers through the elongate shaft and to position a retainer within the jaws. - At the proximal end of the
elongate shaft 452 is thecoil connector 512 which is made of a metal, preferably brass, and is used as a means for connecting theproximal portion 452 a ofelongate shaft 452 to the handle assembly. Dual lumeninner sheath 560 has lumens for end-effector control wire 510 and firingcontrol wire 490.Filler tube connector 562 is used to connect thecoil connector 512 to theelongate shaft 452 and is glued tocoil connector 512 andelongate shaft 452 using an adhesive glue such as cyanoacrylate.Elongate shaft 452 is broken intoproximal shaft section 452 a anddistal shaft section 452 b.Proximal shaft section 452 a is preferably nitinol and has a dovetail laser pattern.Distal shaft section 452 b is preferably stainless steel and has a similar dovetail pattern cut through the wall of the shaft. Other patterns could also be used such as a helical cut as shown inFIG. 16A .FIG. 16B depicts another variation of the plication device where the proximal shaft section is similar to that above but the nut is placed significantly more distally and the stainless steel distal shaft section with a dovetail pattern is replaced with a helical cut creating a ribbon coil.FIG. 16C depicts the placement of the nut and the dovetail patterns of the proximal and distal shaft portions discussed with respect toFIGS. 14A-F above.FIG. 16D depicts the passively articulating jaws of the alternative embodiment discussed above. - A
preferred retainer 500 for us in the present system and method is shown inFIG. 15 .Retainer 500 is comprised of stainless steel or other biocompatible material such as MP35N, platinum, nitinol and cobalt chromium or alloys thereof. The helical retainer may also be made of a or polymeric material such as one made of poly lactic acid (PLA) and/or poly glycolic acid (PGA). The retainer is comprised of a metal alloy with the preferred embodiment containing at least a trace of an element having an atomic number greater than 53 such as platinum to enhance visibility of the retainer under fluoroscopy. Additionally, a sufficient wall thickness should be chosen to ensure visibility under fluoro. The shape of the tip of the distal jaws of the plication device also have an alignment feature when viewed under fluoro that allows the viewer to determine which of 2 orientations (0/180 or 90/270) the jaws are in. In a 0/180 orientation the tip of the jaws form a circle as depicted inFIG. 14F . In a 90/270 orientation the tip of the jaws form a minus as depicted inFIG. 14B . Theretainer 500 is preferably “C” shaped with elongated legs which may vary in length depending on the depth of tissue to be penetrated and the number of retainers that are desired to be housed within the garage of the plication device. Thetips 501 are designed to be folded by the distal tips of the jaws of the end effector during the process of advancement to prevent the retainer from backing out or being pulled out of the plicated tissue. The retainer could be coated with one or more pharmacologically active agents such as heparin for the purpose of reducing thrombotic potential. - The plication device may further comprise a magnetic based location sensor such as those manufactured by Biosense Webster for sensing the location and orientation (six degrees of freedom, x, y, z, roll (Xrot), pitch (Yrot) and yaw (Zrot)) of the distal end of the deflecting guide catheter and for providing location information that may be registered with other preaquired or real-time images or otherwise used to depict the location of the distal end of the deflecting guide catheter on a real-time display map of the heart. Systems such as the Carto® system produced by Biosense Webster would be useful for this purpose. The incorporation of the magnetic based location sensor near the distal tip of the plication device, preferably approximately 28 mm proximal from the distal tip, enables precise orientation of the jaws in order to facilitate placement of the jaws and plication of the tissue. The magnetic location sensors would be placed proximal the distal end of the jaws of the plication device due to shielding if such sensors were placed in the jaws themselves. Location information is then transmitted through electrical conductors to circuitry in the handle of the plication device which is electrically connected to a Carto® mapping system. The Carto® mapping system will then use the location information from the magnetic location sensors in order to extrapolate the location and layout of the distal end of the plication device. A sensor should also be placed in the handle of the plication device that would provide a signal to the Carto® system indicative of the open/closed position of the jaws. With this information the Carto® system will be able to display a real-time image of the heart and the location of the distal end of the plication device within the left ventricle, etc.
- The devices disclosed herein can also be designed to be disposed of after a single use, or they can be designed to be used multiple times. In either case, however, the device can be reconditioned for reuse after at least one use. Reconditioning can include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, the device can be disassembled, and any number of the particular pieces or parts of the device can be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, the device can be reassembled for subsequent use either at a reconditioning facility, or by a surgical team immediately prior to a surgical procedure. Those skilled in the art will appreciate that reconditioning of a device can utilize a variety of techniques for disassembly, cleaning and/or replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.
- The preceding description has been presented with reference to presently preferred embodiments of the invention. Workers skilled in the art and technology to which this invention pertains will appreciate that alterations and changes in the described structure may be practiced without meaningfully departing from the principal, spirit and scope of this invention.
- Accordingly, the foregoing description should not be read as pertaining only to the precise structures described and illustrated in the accompanying drawings, but rather should be read consistent with and as support to the following claims which are to have their fullest and fair scope.
Claims (19)
1. A system for the treatment of mitral valve regurgitation through direct plication annuloplasty of a patient comprising:
a deflecting guide catheter having an elongate body with lumen therethrough ending in a distal opening for insertion through the aortic valve into the left ventricle of the patient;
a plication device having a set of opposing jaws operable to plicate tissue in the mitral valve of the patient;
wherein the plication device comprises at least one retainer for retaining plications in tissue.
2. The system of claim 1 further comprising a crossing catheter having a distal end for insertion through the aortic valve into the left ventricle of the patient;
3. The system of claim 1 further comprising a guidewire for use in guiding the crossing catheter through the vasculature of the patient and into the left ventricle.
4. The system of claim 1 wherein the crossing catheter has a J-shaped distal tip.
5. The system of claim 1 wherein the crossing catheter has a pigtail-shaped distal tip.
6. The system of claim 1 wherein the deflecting guide catheter has a first puller wire attached to a first anchor band near the distal end of the deflecting guide catheter for deflecting the distal end of the deflecting guide catheter in response to proximal movement of the puller wire.
7. The system of claim 6 further comprising a second puller wire for a second anchor band near the distal end of the deflecting guide catheter for deflecting the distal end of the deflecting guide catheter in response to proximal movement of the second puller wire.
8. The system of claim 7 wherein the proximal movement of the second puller wire causes the deflecting guide catheter to deflect in a different plane from the deflection caused by proximal movement of the first puller wire.
9. The system of claim 8 wherein the second puller wire attaches to the second anchor band at a position that is spaced radially apart from the position at which the first puller wire attaches to the first anchor band.
10. The system of claim 1 wherein the plication device has an elongate tubular body comprised of metal with a pattern cut through the metal.
11. The system of claim 10 wherein the pattern is a dovetail pattern.
12. The system of claim 10 wherein the pattern is a helical pattern.
13. The system of claim 10 wherein a proximal section of the elongate tubular body of the plication device is comprised of nitinol and a distal section of the elongate tubular body is comprised of stainless steel.
14. The system of claim 1 wherein the retainer is “c” shaped and comprises two prongs having ends connected by an intermediate member.
15. The method of claim 14 wherein the retainer is comprised of a metal alloy.
16. The method of claim 14 wherein the retainer is comprised of stainless steel, MP35N, platinum, nitinol, cobalt chromium or alloys thereof.
17. The method of claim 14 wherein the retainer is comprised of a alloy containing at least a trace of an element having an atomic number greater than 53 to enhance visibility of the retainer under fluoroscopy.
18. The method of claim 14 wherein the retainer is comprised of poly lactic acid (PLA) and/or poly glycolic acid (PGA).
19. The system of claim 14 wherein the ends of at least one prong may be deformed to prevent the retainer from leaving the plicated tissue.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/534,158 US20130172990A1 (en) | 2007-10-19 | 2012-06-27 | Method and system for plicating tissue in a minimally invasive medical procedure for the treatment of mitral valve regurgitation |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98130307P | 2007-10-19 | 2007-10-19 | |
US12/249,388 US8226709B2 (en) | 2007-10-19 | 2008-10-10 | Method and system for plicating tissue in a minimally invasive medical procedure for the treatment of mitral valve regurgitation |
US13/534,158 US20130172990A1 (en) | 2007-10-19 | 2012-06-27 | Method and system for plicating tissue in a minimally invasive medical procedure for the treatment of mitral valve regurgitation |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/249,388 Division US8226709B2 (en) | 2007-10-19 | 2008-10-10 | Method and system for plicating tissue in a minimally invasive medical procedure for the treatment of mitral valve regurgitation |
Publications (1)
Publication Number | Publication Date |
---|---|
US20130172990A1 true US20130172990A1 (en) | 2013-07-04 |
Family
ID=40564271
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/249,551 Abandoned US20090105816A1 (en) | 2007-10-19 | 2008-10-10 | System using a helical retainer in the direct plication annuloplasty treatment of mitral valve regurgitation |
US12/249,675 Abandoned US20090105815A1 (en) | 2007-10-19 | 2008-10-10 | Push-in retainer system for use in the direct plication annuloplasty treatment of mitral valve regurgitation |
US12/249,388 Active 2030-11-29 US8226709B2 (en) | 2007-10-19 | 2008-10-10 | Method and system for plicating tissue in a minimally invasive medical procedure for the treatment of mitral valve regurgitation |
US13/534,158 Abandoned US20130172990A1 (en) | 2007-10-19 | 2012-06-27 | Method and system for plicating tissue in a minimally invasive medical procedure for the treatment of mitral valve regurgitation |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/249,551 Abandoned US20090105816A1 (en) | 2007-10-19 | 2008-10-10 | System using a helical retainer in the direct plication annuloplasty treatment of mitral valve regurgitation |
US12/249,675 Abandoned US20090105815A1 (en) | 2007-10-19 | 2008-10-10 | Push-in retainer system for use in the direct plication annuloplasty treatment of mitral valve regurgitation |
US12/249,388 Active 2030-11-29 US8226709B2 (en) | 2007-10-19 | 2008-10-10 | Method and system for plicating tissue in a minimally invasive medical procedure for the treatment of mitral valve regurgitation |
Country Status (8)
Country | Link |
---|---|
US (4) | US20090105816A1 (en) |
EP (3) | EP2219559A1 (en) |
JP (4) | JP5646333B2 (en) |
CN (4) | CN104274258B (en) |
AU (3) | AU2008312339B2 (en) |
CA (3) | CA2702960A1 (en) |
IL (3) | IL205113A (en) |
WO (3) | WO2009052397A1 (en) |
Families Citing this family (118)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006097931A2 (en) | 2005-03-17 | 2006-09-21 | Valtech Cardio, Ltd. | Mitral valve treatment techniques |
US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
US8449606B2 (en) | 2005-10-26 | 2013-05-28 | Cardiosolutions, Inc. | Balloon mitral spacer |
US8852270B2 (en) | 2007-11-15 | 2014-10-07 | Cardiosolutions, Inc. | Implant delivery system and method |
US8216302B2 (en) | 2005-10-26 | 2012-07-10 | Cardiosolutions, Inc. | Implant delivery and deployment system and method |
US8778017B2 (en) | 2005-10-26 | 2014-07-15 | Cardiosolutions, Inc. | Safety for mitral valve implant |
US9259317B2 (en) | 2008-06-13 | 2016-02-16 | Cardiosolutions, Inc. | System and method for implanting a heart implant |
US7785366B2 (en) | 2005-10-26 | 2010-08-31 | Maurer Christopher W | Mitral spacer |
US8092525B2 (en) | 2005-10-26 | 2012-01-10 | Cardiosolutions, Inc. | Heart valve implant |
WO2010004546A1 (en) | 2008-06-16 | 2010-01-14 | Valtech Cardio, Ltd. | Annuloplasty devices and methods of delivery therefor |
US11259924B2 (en) | 2006-12-05 | 2022-03-01 | Valtech Cardio Ltd. | Implantation of repair devices in the heart |
US9883943B2 (en) | 2006-12-05 | 2018-02-06 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
US8480730B2 (en) | 2007-05-14 | 2013-07-09 | Cardiosolutions, Inc. | Solid construct mitral spacer |
US8197464B2 (en) * | 2007-10-19 | 2012-06-12 | Cordis Corporation | Deflecting guide catheter for use in a minimally invasive medical procedure for the treatment of mitral valve regurgitation |
US8597347B2 (en) | 2007-11-15 | 2013-12-03 | Cardiosolutions, Inc. | Heart regurgitation method and apparatus |
US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
US8591460B2 (en) * | 2008-06-13 | 2013-11-26 | Cardiosolutions, Inc. | Steerable catheter and dilator and system and method for implanting a heart implant |
US8905961B2 (en) * | 2008-12-19 | 2014-12-09 | St. Jude Medical, Inc. | Systems, apparatuses, and methods for cardiovascular conduits and connectors |
US8147542B2 (en) | 2008-12-22 | 2012-04-03 | Valtech Cardio, Ltd. | Adjustable repair chords and spool mechanism therefor |
US8241351B2 (en) | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
US8715342B2 (en) | 2009-05-07 | 2014-05-06 | Valtech Cardio, Ltd. | Annuloplasty ring with intra-ring anchoring |
US8926696B2 (en) | 2008-12-22 | 2015-01-06 | Valtech Cardio, Ltd. | Adjustable annuloplasty devices and adjustment mechanisms therefor |
US8545553B2 (en) | 2009-05-04 | 2013-10-01 | Valtech Cardio, Ltd. | Over-wire rotation tool |
US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US9011530B2 (en) | 2008-12-22 | 2015-04-21 | Valtech Cardio, Ltd. | Partially-adjustable annuloplasty structure |
US8353956B2 (en) | 2009-02-17 | 2013-01-15 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
US8690939B2 (en) | 2009-10-29 | 2014-04-08 | Valtech Cardio, Ltd. | Method for guide-wire based advancement of a rotation assembly |
US10098737B2 (en) * | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US8277502B2 (en) * | 2009-10-29 | 2012-10-02 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US9011520B2 (en) | 2009-10-29 | 2015-04-21 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US9180007B2 (en) | 2009-10-29 | 2015-11-10 | Valtech Cardio, Ltd. | Apparatus and method for guide-wire based advancement of an adjustable implant |
EP2506777B1 (en) | 2009-12-02 | 2020-11-25 | Valtech Cardio, Ltd. | Combination of spool assembly coupled to a helical anchor and delivery tool for implantation thereof |
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
DE102010013917A1 (en) * | 2010-04-01 | 2011-10-06 | Karl Storz Gmbh & Co. Kg | Medical instrument for a minimally invasive procedure |
US8876892B2 (en) * | 2010-04-21 | 2014-11-04 | Medtronic, Inc. | Prosthetic heart valve delivery system with spacing |
US8790394B2 (en) | 2010-05-24 | 2014-07-29 | Valtech Cardio, Ltd. | Adjustable artificial chordeae tendineae with suture loops |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US10792152B2 (en) | 2011-06-23 | 2020-10-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US9918840B2 (en) | 2011-06-23 | 2018-03-20 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US9364326B2 (en) | 2011-06-29 | 2016-06-14 | Mitralix Ltd. | Heart valve repair devices and methods |
US8979733B2 (en) * | 2011-09-23 | 2015-03-17 | Coloplast A/S | Synthetic urethra with closure device |
US8858623B2 (en) | 2011-11-04 | 2014-10-14 | Valtech Cardio, Ltd. | Implant having multiple rotational assemblies |
US9724192B2 (en) | 2011-11-08 | 2017-08-08 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
US8831707B2 (en) * | 2011-11-16 | 2014-09-09 | Cook Medical Technologies Llc | Tip deflecting puncture needle |
CN102860846B (en) * | 2012-09-05 | 2015-08-12 | 中国人民解放军第一0一医院 | A kind of Tricuspid valve edge-to-edge jaw device can implanted through conduit |
EP2900150B1 (en) | 2012-09-29 | 2018-04-18 | Mitralign, Inc. | Plication lock delivery system |
US10376266B2 (en) | 2012-10-23 | 2019-08-13 | Valtech Cardio, Ltd. | Percutaneous tissue anchor techniques |
US9949828B2 (en) | 2012-10-23 | 2018-04-24 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
CN104780777A (en) * | 2012-10-30 | 2015-07-15 | 龟甲万株式会社 | Powdery seasoning and method for manufacturing same |
US9549666B2 (en) | 2012-11-10 | 2017-01-24 | Curvo Medical, Inc. | Coaxial micro-endoscope |
US9233225B2 (en) | 2012-11-10 | 2016-01-12 | Curvo Medical, Inc. | Coaxial bi-directional catheter |
WO2014087402A1 (en) | 2012-12-06 | 2014-06-12 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
EP2948103B1 (en) | 2013-01-24 | 2022-12-07 | Cardiovalve Ltd | Ventricularly-anchored prosthetic valves |
WO2014134183A1 (en) | 2013-02-26 | 2014-09-04 | Mitralign, Inc. | Devices and methods for percutaneous tricuspid valve repair |
US9149360B2 (en) | 2013-03-12 | 2015-10-06 | Edwards Lifesciences Corporation | Dynamic annuloplasty ring sizer |
US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
US9232998B2 (en) | 2013-03-15 | 2016-01-12 | Cardiosolutions Inc. | Trans-apical implant systems, implants and methods |
CN105283214B (en) | 2013-03-15 | 2018-10-16 | 北京泰德制药股份有限公司 | Translate conduit, system and its application method |
US9289297B2 (en) | 2013-03-15 | 2016-03-22 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
JP6731339B2 (en) | 2013-06-14 | 2020-07-29 | カーディオソリューションズ インコーポレイテッドCardiosolutions, Inc. | Mitral valve spacer and implantation system and method thereof |
US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
US10299793B2 (en) | 2013-10-23 | 2019-05-28 | Valtech Cardio, Ltd. | Anchor magazine |
CN103654881B (en) * | 2013-10-23 | 2015-10-28 | 北京工业大学 | For the lobe leaf shaping apparatus of aortic valve free edge suspension operation |
US9610162B2 (en) * | 2013-12-26 | 2017-04-04 | Valtech Cardio, Ltd. | Implantation of flexible implant |
KR101613268B1 (en) | 2014-01-02 | 2016-04-18 | 재단법인 아산사회복지재단 | Delivery apparatus for medical instrument |
US9700412B2 (en) | 2014-06-26 | 2017-07-11 | Mitralix Ltd. | Heart valve repair devices for placement in ventricle and delivery systems for implanting heart valve repair devices |
EP4331503A2 (en) | 2014-10-14 | 2024-03-06 | Edwards Lifesciences Innovation (Israel) Ltd. | Leaflet-restraining techniques |
CN105615931B (en) * | 2014-10-29 | 2017-12-19 | 上海理工大学 | The Minimally Invasive Surgery apparatus of mitral regurgitation is repaired through apex of the heart implantable artificial chordae tendineae |
US10512460B2 (en) | 2014-12-19 | 2019-12-24 | Renzo Cecere | Surgical method and system for performing the same |
US10188392B2 (en) * | 2014-12-19 | 2019-01-29 | Abbott Cardiovascular Systems, Inc. | Grasping for tissue repair |
BR112017014871B1 (en) | 2015-01-12 | 2022-11-29 | Epygon | DEVICE FOR TRANSCATHETER HEART VALVE LEAFLET REPAIR UNDER TRIANGULAR RESECTION TECHNIQUE |
CN110141399B (en) | 2015-02-05 | 2021-07-27 | 卡迪尔维尔福股份有限公司 | Prosthetic valve with axially sliding frame |
US10105226B2 (en) | 2015-02-10 | 2018-10-23 | Edwards Lifesciences Corporation | Offset cardiac leaflet coaptation element |
US20160256269A1 (en) | 2015-03-05 | 2016-09-08 | Mitralign, Inc. | Devices for treating paravalvular leakage and methods use thereof |
CR20170480A (en) | 2015-04-30 | 2018-02-21 | Valtech Cardio Ltd | Annuloplasty technologies |
US10314707B2 (en) | 2015-06-09 | 2019-06-11 | Edwards Lifesciences, Llc | Asymmetric mitral annuloplasty band |
WO2017096362A1 (en) | 2015-12-04 | 2017-06-08 | Barrish Mark D | Lateral articulation anchors for catheters and other uses |
US10751182B2 (en) | 2015-12-30 | 2020-08-25 | Edwards Lifesciences Corporation | System and method for reshaping right heart |
WO2017117370A2 (en) | 2015-12-30 | 2017-07-06 | Mitralign, Inc. | System and method for reducing tricuspid regurgitation |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US10806899B2 (en) | 2016-02-17 | 2020-10-20 | Project Moray, Inc. | Local contraction of flexible bodies using balloon expansion for extension-contraction catheter articulation and other uses |
US11420021B2 (en) | 2016-03-25 | 2022-08-23 | Project Moray, Inc. | Fluid-actuated displacement for catheters, continuum manipulators, and other uses |
US10512757B2 (en) | 2016-03-25 | 2019-12-24 | Project Moray, Inc. | Fluid-actuated sheath displacement and articulation behavior improving systems, devices, and methods for catheters, continuum manipulators, and other uses |
US10441748B2 (en) | 2016-05-16 | 2019-10-15 | Gyrus Acmi, Inc. | Flexible and/or pushable tubular device |
US10702274B2 (en) | 2016-05-26 | 2020-07-07 | Edwards Lifesciences Corporation | Method and system for closing left atrial appendage |
GB201611910D0 (en) | 2016-07-08 | 2016-08-24 | Valtech Cardio Ltd | Adjustable annuloplasty device with alternating peaks and troughs |
CN106175986B (en) * | 2016-07-26 | 2017-12-01 | 复旦大学附属中山医院 | A kind of valve clamping machine |
EP3496664B1 (en) | 2016-08-10 | 2021-09-29 | Cardiovalve Ltd | Prosthetic valve with concentric frames |
EP3518748A4 (en) | 2016-09-28 | 2020-06-03 | Project Moray, Inc. | Base station, charging station, and/or server for robotic catheter systems and other uses, and improved articulated devices and systems |
CN110603005A (en) | 2016-09-28 | 2019-12-20 | 项目莫里股份有限公司 | Delivery methods and devices for arrhythmia diagnosis and/or treatment, and robotic systems for other uses |
US10675017B2 (en) | 2017-02-07 | 2020-06-09 | Edwards Lifesciences Corporation | Transcatheter heart valve leaflet plication |
CN110913940B (en) * | 2017-03-06 | 2023-04-28 | 科林达斯公司 | Replacement of percutaneous devices |
KR102303600B1 (en) * | 2017-03-17 | 2021-09-23 | 임파서블 오브젝츠, 아이앤씨. | Method and apparatus for powder system recycler for printing process |
US11045627B2 (en) | 2017-04-18 | 2021-06-29 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
WO2018200537A1 (en) | 2017-04-25 | 2018-11-01 | Project Moray, Inc. | Matrix supported balloon articulation systems, devices, and methods for catheters and other users |
US10806573B2 (en) * | 2017-08-22 | 2020-10-20 | Edwards Lifesciences Corporation | Gear drive mechanism for heart valve delivery apparatus |
PT3498224T (en) * | 2017-10-19 | 2022-03-02 | Shanghai Hanyu Medical Tech Co Ltd | Valve clip device |
US10835221B2 (en) | 2017-11-02 | 2020-11-17 | Valtech Cardio, Ltd. | Implant-cinching devices and systems |
US11135062B2 (en) | 2017-11-20 | 2021-10-05 | Valtech Cardio Ltd. | Cinching of dilated heart muscle |
CN109966011B (en) * | 2017-12-28 | 2021-08-17 | 深圳市先健呼吸科技有限公司 | Delivery and retrieval device and system for an implant having at least one cavity |
CN109984876B (en) * | 2017-12-29 | 2021-10-22 | 深圳市先健呼吸科技有限公司 | Retrieval system and sheath for a lung volume reduction implant |
EP3964175A1 (en) * | 2018-01-09 | 2022-03-09 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
EP3743015A1 (en) | 2018-01-24 | 2020-12-02 | Valtech Cardio, Ltd. | Contraction of an annuloplasty structure |
WO2019145941A1 (en) | 2018-01-26 | 2019-08-01 | Valtech Cardio, Ltd. | Techniques for facilitating heart valve tethering and chord replacement |
US11026791B2 (en) | 2018-03-20 | 2021-06-08 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
US11285003B2 (en) | 2018-03-20 | 2022-03-29 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11026673B2 (en) | 2018-05-10 | 2021-06-08 | Edwards Lifesciences Corporation | Corkscrew tissue anchor |
CR20210020A (en) | 2018-07-12 | 2021-07-21 | Valtech Cardio Ltd | Annuloplasty systems and locking tools therefor |
KR20220122966A (en) | 2019-10-29 | 2022-09-05 | 에드워즈 라이프사이언시스 이노베이션 (이스라엘) 리미티드 | Annuloplasty and Tissue Anchor Techniques |
US20230056943A1 (en) * | 2019-12-13 | 2023-02-23 | Dinesh Vyas | Stapler apparatus and methods for use |
US20210177402A1 (en) | 2019-12-13 | 2021-06-17 | Dinesh Vyas | Stapler apparatus and methods for use |
CN111761609B (en) * | 2020-07-08 | 2022-06-03 | 天津大学 | Flexible continuum robot based on contact auxiliary structure |
US11872357B2 (en) | 2020-11-09 | 2024-01-16 | Agile Devices, Inc. | Devices for steering catheters |
DE212022000102U1 (en) * | 2021-06-13 | 2023-07-25 | Micro-Tech (Nanjing) Co., Ltd. | Endoscopic clamp |
US11660094B2 (en) * | 2021-09-29 | 2023-05-30 | Covidien Lp | Surgical fastening instrument with two-part surgical fasteners |
CN114176841B (en) * | 2021-12-24 | 2023-07-07 | 上海御瓣医疗科技有限公司 | Heart valve forming ring |
Citations (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5049153A (en) * | 1989-12-26 | 1991-09-17 | Nakao Naomi L | Endoscopic stapling device and method |
US5403326A (en) * | 1993-02-01 | 1995-04-04 | The Regents Of The University Of California | Method for performing a gastric wrap of the esophagus for use in the treatment of esophageal reflux |
US5716367A (en) * | 1995-10-18 | 1998-02-10 | Nissho Corporation | Catheter assembly for intracardiac suture |
US20020078967A1 (en) * | 2000-12-06 | 2002-06-27 | Robert Sixto | Methods for the endoluminal treatment of gastroesophageal reflux disease (GERD) |
US20020103492A1 (en) * | 1999-05-20 | 2002-08-01 | Kaplan Aaron V. | Methods and apparatus for transpericardial left atrial appendage closure |
US20020198549A1 (en) * | 2001-06-25 | 2002-12-26 | Syntheon, Llc | Surgical clip |
US20040010245A1 (en) * | 1999-06-22 | 2004-01-15 | Cerier Jeffrey C. | Method and devices for tissue reconfiguration |
US20040044364A1 (en) * | 2002-08-29 | 2004-03-04 | Devries Robert | Tissue fasteners and related deployment systems and methods |
US20040059354A1 (en) * | 2002-09-20 | 2004-03-25 | Smith Kevin W. | Surgical fastener particularly for the treatment of gastroesophageal reflux disease (GERD) |
US20040138682A1 (en) * | 2002-07-11 | 2004-07-15 | Olympus Optical Co., Ltd. | Endoscopic suture apparatus |
US20040147958A1 (en) * | 2002-12-11 | 2004-07-29 | Usgi Medical | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US20040193185A1 (en) * | 2003-03-25 | 2004-09-30 | Inscope Development, Llc | Surgical jaw assembly with increased mechanical advantage |
US20040193193A1 (en) * | 1999-06-22 | 2004-09-30 | Ndo Surgical, Inc., A Massachusetts Corporation | Tissue reconfiguration |
US6808491B2 (en) * | 2001-05-21 | 2004-10-26 | Syntheon, Llc | Methods and apparatus for on-endoscope instruments having end effectors and combinations of on-endoscope and through-endoscope instruments |
US20040225183A1 (en) * | 1999-06-25 | 2004-11-11 | Usgi Medical | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US20050119524A1 (en) * | 2002-08-07 | 2005-06-02 | Olympus Optical Co., Ltd. | Endoscopic treatment system |
US6921361B2 (en) * | 2000-07-24 | 2005-07-26 | Olympus Corporation | Endoscopic instrument for forming an artificial valve |
US20050192629A1 (en) * | 1999-06-25 | 2005-09-01 | Usgi Medical Inc. | Methods and apparatus for creating and regulating a gastric stoma |
US20050251166A1 (en) * | 2004-05-07 | 2005-11-10 | Usgi Medical Inc. | Tissue manipulation and securement system |
US20050272977A1 (en) * | 2004-04-14 | 2005-12-08 | Usgi Medical Inc. | Methods and apparatus for performing endoluminal procedures |
US20060178560A1 (en) * | 2003-01-15 | 2006-08-10 | Usgi Medical, Inc. | Endoluminal tool deployment system |
US20060178562A1 (en) * | 2005-02-10 | 2006-08-10 | Usgi Medical Inc. | Apparatus and methods for obtaining endoluminal access with a steerable guide having a variable pivot |
US20070093857A1 (en) * | 2005-10-26 | 2007-04-26 | Campbell Rogers | Devices and methods for treating mitral valve regurgitation |
US20070142849A1 (en) * | 2005-12-16 | 2007-06-21 | Usgi Medical, Inc. | Helical tissue manipulation instruments and methods of use |
US7618426B2 (en) * | 2002-12-11 | 2009-11-17 | Usgi Medical, Inc. | Apparatus and methods for forming gastrointestinal tissue approximations |
US7736374B2 (en) * | 2004-05-07 | 2010-06-15 | Usgi Medical, Inc. | Tissue manipulation and securement system |
US8062314B2 (en) * | 2000-12-06 | 2011-11-22 | Ethicon Endo-Surgery, Inc. | Methods for the endoluminal treatment of gastroesophageal reflux disease (GERD) |
Family Cites Families (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US118151A (en) * | 1871-08-15 | Improvement in propelling mechanisms for vessels | ||
US93857A (en) * | 1869-08-17 | James abercrombie burden | ||
US213689A (en) * | 1879-03-25 | Improvement in fountain-pens | ||
US233142A (en) * | 1880-10-12 | James b | ||
US106403A (en) * | 1870-08-16 | Improvement in school-desk | ||
SU715082A1 (en) | 1977-01-24 | 1980-02-15 | Всесоюзный научно-исследовательский и испытательный институт медицинской техники | Surgical suturing apparatus |
US4636346A (en) | 1984-03-08 | 1987-01-13 | Cordis Corporation | Preparing guiding catheter |
US4586923A (en) * | 1984-06-25 | 1986-05-06 | Cordis Corporation | Curving tip catheter |
DE3941108C1 (en) | 1989-12-13 | 1991-06-27 | Richard Wolf Gmbh, 7134 Knittlingen, De | |
US5088979A (en) | 1990-10-11 | 1992-02-18 | Wilson-Cook Medical Inc. | Method for esophageal invagination and devices useful therein |
US5437266A (en) * | 1992-07-02 | 1995-08-01 | Mcpherson; William | Coil screw surgical retractor |
DE4304353A1 (en) | 1992-10-24 | 1994-04-28 | Helmut Dipl Ing Wurster | Suturing device used in endoscopic surgical operations - has helical needle with fixed non-traumatic thread held and rotated by rollers attached to instrument head extended into patients body. |
US5368564A (en) * | 1992-12-23 | 1994-11-29 | Angeion Corporation | Steerable catheter |
US5487757A (en) | 1993-07-20 | 1996-01-30 | Medtronic Cardiorhythm | Multicurve deflectable catheter |
US5582616A (en) * | 1994-08-05 | 1996-12-10 | Origin Medsystems, Inc. | Surgical helical fastener with applicator |
US5738631A (en) * | 1994-10-27 | 1998-04-14 | Circon Corporation | Ratchet control mechanism for an endoscope |
US6132438A (en) * | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
US6482224B1 (en) * | 1996-08-22 | 2002-11-19 | The Trustees Of Columbia University In The City Of New York | Endovascular flexible stapling device |
US5830221A (en) * | 1996-09-20 | 1998-11-03 | United States Surgical Corporation | Coil fastener applier |
CA2224366C (en) * | 1996-12-11 | 2006-10-31 | Ethicon, Inc. | Meniscal repair device |
US5968010A (en) * | 1997-04-30 | 1999-10-19 | Beth Israel Deaconess Medical Center, Inc. | Method for transvenously accessing the pericardial space via the right atrium |
WO1999000059A1 (en) | 1997-06-27 | 1999-01-07 | The Trustees Of Columbia University In The City Of New York | Method and apparatus for circulatory valve repair |
US5997556A (en) | 1997-06-30 | 1999-12-07 | Eva Corporation | Surgical fastener |
US6086600A (en) * | 1997-11-03 | 2000-07-11 | Symbiosis Corporation | Flexible endoscopic surgical instrument for invagination and fundoplication |
US20020095175A1 (en) * | 1998-02-24 | 2002-07-18 | Brock David L. | Flexible instrument |
US6015416A (en) | 1998-02-26 | 2000-01-18 | Ethicon Endo-Surgery, Inc. | Surgical anastomosis instrument |
US6960217B2 (en) * | 2001-11-28 | 2005-11-01 | Aptus Endosystems, Inc. | Endovascular aneurysm repair system |
US6113611A (en) * | 1998-05-28 | 2000-09-05 | Advanced Vascular Technologies, Llc | Surgical fastener and delivery system |
US6165164A (en) | 1999-03-29 | 2000-12-26 | Cordis Corporation | Catheter for injecting therapeutic and diagnostic agents |
US6165183A (en) * | 1998-07-15 | 2000-12-26 | St. Jude Medical, Inc. | Mitral and tricuspid valve repair |
US6352503B1 (en) * | 1998-07-17 | 2002-03-05 | Olympus Optical Co., Ltd. | Endoscopic surgery apparatus |
US6267781B1 (en) * | 1998-08-31 | 2001-07-31 | Quantum Therapeutics Corp. | Medical device and methods for treating valvular annulus |
ATE484241T1 (en) | 1999-04-09 | 2010-10-15 | Evalve Inc | METHOD AND DEVICE FOR HEART VALVE REPAIR |
US7563267B2 (en) * | 1999-04-09 | 2009-07-21 | Evalve, Inc. | Fixation device and methods for engaging tissue |
US10327743B2 (en) * | 1999-04-09 | 2019-06-25 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
US6494888B1 (en) | 1999-06-22 | 2002-12-17 | Ndo Surgical, Inc. | Tissue reconfiguration |
US6835200B2 (en) * | 1999-06-22 | 2004-12-28 | Ndo Surgical. Inc. | Method and devices for tissue reconfiguration |
WO2001030245A1 (en) * | 1999-10-26 | 2001-05-03 | H Randall Craig | Helical suture instrument |
US6450948B1 (en) * | 1999-11-02 | 2002-09-17 | Vista Medical Technologies, Inc. | Deflecting tip for surgical cannula |
US6461364B1 (en) * | 2000-01-05 | 2002-10-08 | Integrated Vascular Systems, Inc. | Vascular sheath with bioabsorbable puncture site closure apparatus and methods of use |
CA2395235A1 (en) * | 2000-01-05 | 2001-07-12 | Integrated Vascular Systems, Inc. | Apparatus for closing tissue punctures |
US6592596B1 (en) * | 2000-05-10 | 2003-07-15 | Scimed Life Systems, Inc. | Devices and related methods for securing a tissue fold |
SE0002878D0 (en) * | 2000-08-11 | 2000-08-11 | Kimblad Ola | Device and method of treatment of atrioventricular regurgitation |
AU2001286704A1 (en) * | 2000-08-24 | 2002-03-04 | Surgical Connections, Inc. | Surgical stabilizer devices and methods |
US6520973B1 (en) * | 2000-08-30 | 2003-02-18 | Ethicon Endo-Surgery, Inc. | Anastomosis device having an improved needle driver |
US6736828B1 (en) | 2000-09-29 | 2004-05-18 | Scimed Life Systems, Inc. | Method for performing endoluminal fundoplication and apparatus for use in the method |
US8690910B2 (en) * | 2000-12-07 | 2014-04-08 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US6619291B2 (en) * | 2001-04-24 | 2003-09-16 | Edwin J. Hlavka | Method and apparatus for catheter-based annuloplasty |
US7037334B1 (en) * | 2001-04-24 | 2006-05-02 | Mitralign, Inc. | Method and apparatus for catheter-based annuloplasty using local plications |
US7083629B2 (en) * | 2001-05-30 | 2006-08-01 | Satiety, Inc. | Overtube apparatus for insertion into a body |
US6575971B2 (en) * | 2001-11-15 | 2003-06-10 | Quantum Cor, Inc. | Cardiac valve leaflet stapler device and methods thereof |
US6978176B2 (en) * | 2001-12-08 | 2005-12-20 | Lattouf Omar M | Treatment for patient with congestive heart failure |
US7048754B2 (en) * | 2002-03-01 | 2006-05-23 | Evalve, Inc. | Suture fasteners and methods of use |
US20070213689A1 (en) * | 2002-03-22 | 2007-09-13 | Grewe David D | Deflectable tip infusion guidewire |
US7077850B2 (en) * | 2002-05-01 | 2006-07-18 | Scimed Life Systems, Inc. | Tissue fastening devices and related insertion tools and methods |
AU2003245507A1 (en) * | 2002-06-13 | 2003-12-31 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US7029468B2 (en) | 2002-06-25 | 2006-04-18 | Enpath Medical, Inc. | Catheter assembly with side wall exit lumen and method therefor |
WO2004026113A2 (en) | 2002-09-23 | 2004-04-01 | Eva Corporation | Apparatus and method for reducing fluid loss during a surgical procedure |
US7087064B1 (en) * | 2002-10-15 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Apparatuses and methods for heart valve repair |
EP1555949A4 (en) * | 2002-10-21 | 2009-07-01 | Mitralign Inc | Method and apparatus for performing catheter-based annuloplasty using local plications |
US7404824B1 (en) * | 2002-11-15 | 2008-07-29 | Advanced Cardiovascular Systems, Inc. | Valve aptation assist device |
US6945978B1 (en) | 2002-11-15 | 2005-09-20 | Advanced Cardiovascular Systems, Inc. | Heart valve catheter |
EP1608297A2 (en) * | 2003-03-18 | 2005-12-28 | St. Jude Medical, Inc. | Body tissue remodeling apparatus |
US7179291B2 (en) | 2003-05-27 | 2007-02-20 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
EP1646319A1 (en) * | 2003-07-11 | 2006-04-19 | Endogun Medical Systems Ltd. | Surgical fasteners and devices for surgical fastening |
CN1856282A (en) * | 2003-07-23 | 2006-11-01 | 维亚科公司 | Method and apparatus for improving mitral valve function |
US7588555B2 (en) * | 2003-09-24 | 2009-09-15 | Enpath Medical, Inc. | Bi-directional catheter assembly and method therefor |
US20050075654A1 (en) * | 2003-10-06 | 2005-04-07 | Brian Kelleher | Methods and devices for soft tissue securement |
US7347863B2 (en) | 2004-05-07 | 2008-03-25 | Usgi Medical, Inc. | Apparatus and methods for manipulating and securing tissue |
US20050251189A1 (en) | 2004-05-07 | 2005-11-10 | Usgi Medical Inc. | Multi-position tissue manipulation assembly |
US7431726B2 (en) | 2003-12-23 | 2008-10-07 | Mitralign, Inc. | Tissue fastening systems and methods utilizing magnetic guidance |
US8864822B2 (en) * | 2003-12-23 | 2014-10-21 | Mitralign, Inc. | Devices and methods for introducing elements into tissue |
US7618427B2 (en) * | 2003-12-29 | 2009-11-17 | Ethicon Endo-Surgery, Inc. | Device and method for intralumenal anastomosis |
US7708684B2 (en) * | 2004-02-27 | 2010-05-04 | Satiety, Inc. | Methods and devices for reducing hollow organ volume |
US20050216036A1 (en) * | 2004-03-29 | 2005-09-29 | Nakao Naomi L | Endoscopic fastening system with multiple fasteners |
US7833238B2 (en) * | 2004-04-19 | 2010-11-16 | Granit Medical Innovations, Llc | Endoscopic anchoring device and associated method |
US8216255B2 (en) | 2004-06-14 | 2012-07-10 | Ethicon Endo-Surgery, Inc. | Endoscopic clip applier actuator |
US7931661B2 (en) * | 2004-06-14 | 2011-04-26 | Usgi Medical, Inc. | Apparatus and methods for performing transluminal gastrointestinal procedures |
US7011048B2 (en) * | 2004-07-22 | 2006-03-14 | Ener1, Inc. | Method and apparatus for liquid fuel preparation to improve combustion |
US20060135970A1 (en) * | 2004-11-15 | 2006-06-22 | Laurent Schaller | Catheter-based tissue remodeling devices and methods |
US7860555B2 (en) * | 2005-02-02 | 2010-12-28 | Voyage Medical, Inc. | Tissue visualization and manipulation system |
US7758594B2 (en) | 2005-05-20 | 2010-07-20 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US8951285B2 (en) * | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
JP4601500B2 (en) | 2005-07-06 | 2010-12-22 | 独立行政法人情報通信研究機構 | Data receiving method and apparatus |
US8252006B2 (en) * | 2005-08-05 | 2012-08-28 | Ethicon Endo-Surgery, Inc. | Single pass gastric restriction with a corkscrew style wall anchor |
US20090030434A1 (en) * | 2005-08-11 | 2009-01-29 | Endogun Medical Systems Ltd. | Surgical Fasteners and Devices for Surgical Fasteners |
DE102005042369A1 (en) * | 2005-09-07 | 2007-03-15 | Biotronik Crm Patent Ag | Screw-in electrode probe for cardiac application |
WO2007062054A2 (en) * | 2005-11-21 | 2007-05-31 | The Brigham And Women's Hospital, Inc. | Percutaneous cardiac valve repair with adjustable artificial chordae |
US7799038B2 (en) * | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
US20070265702A1 (en) * | 2006-01-27 | 2007-11-15 | Lattouf Omar M | Percutaneous treatment for heart valves |
EP2010102B1 (en) * | 2006-04-12 | 2019-06-12 | Medtronic Vascular, Inc. | Annuloplasty device having a helical anchor |
WO2007134258A2 (en) | 2006-05-12 | 2007-11-22 | Vytronus, Inc. | Device for ablating body tissue |
US20080033241A1 (en) * | 2006-08-01 | 2008-02-07 | Ruey-Feng Peh | Left atrial appendage closure |
US7731706B2 (en) * | 2006-12-29 | 2010-06-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | True angular catheter shaft deflection apparatus |
US8845723B2 (en) * | 2007-03-13 | 2014-09-30 | Mitralign, Inc. | Systems and methods for introducing elements into tissue |
US7799040B2 (en) * | 2007-04-04 | 2010-09-21 | Ethicon Endo-Surgery, Inc. | Device for plicating and fastening gastric tissue |
CA2696993C (en) * | 2007-07-18 | 2017-01-03 | Samuel T. Crews | Endoscopic implant system and method |
US20090275964A1 (en) | 2008-05-01 | 2009-11-05 | Zeiner Mark S | Method of rolling stomach tissue so as to maximize the contact surface area of a fold |
-
2008
- 2008-10-10 US US12/249,551 patent/US20090105816A1/en not_active Abandoned
- 2008-10-10 US US12/249,675 patent/US20090105815A1/en not_active Abandoned
- 2008-10-10 US US12/249,388 patent/US8226709B2/en active Active
- 2008-10-17 EP EP08839231A patent/EP2219559A1/en not_active Withdrawn
- 2008-10-17 CN CN201410215720.XA patent/CN104274258B/en not_active Expired - Fee Related
- 2008-10-17 JP JP2010530149A patent/JP5646333B2/en not_active Expired - Fee Related
- 2008-10-17 AU AU2008312339A patent/AU2008312339B2/en not_active Ceased
- 2008-10-17 WO PCT/US2008/080337 patent/WO2009052397A1/en active Application Filing
- 2008-10-17 WO PCT/US2008/080349 patent/WO2009052409A1/en active Application Filing
- 2008-10-17 CN CN200880121405.3A patent/CN101917935B/en not_active Expired - Fee Related
- 2008-10-17 EP EP08840406A patent/EP2219560A1/en not_active Withdrawn
- 2008-10-17 CN CN2008801215569A patent/CN101902990B/en not_active Expired - Fee Related
- 2008-10-17 AU AU2008312327A patent/AU2008312327B2/en not_active Ceased
- 2008-10-17 CN CN200880121404.9A patent/CN101917934B/en not_active Expired - Fee Related
- 2008-10-17 CA CA2702960A patent/CA2702960A1/en not_active Abandoned
- 2008-10-17 CA CA2702948A patent/CA2702948C/en active Active
- 2008-10-17 EP EP08839785A patent/EP2217173A1/en not_active Withdrawn
- 2008-10-17 JP JP2010530147A patent/JP5683956B2/en not_active Expired - Fee Related
- 2008-10-17 WO PCT/US2008/080345 patent/WO2009052405A1/en active Application Filing
- 2008-10-17 JP JP2010530151A patent/JP5646334B2/en not_active Expired - Fee Related
- 2008-10-17 CA CA2702954A patent/CA2702954C/en active Active
- 2008-10-17 AU AU2008312335A patent/AU2008312335B2/en not_active Ceased
-
2010
- 2010-04-15 IL IL205113A patent/IL205113A/en active IP Right Grant
- 2010-04-15 IL IL205116A patent/IL205116A/en not_active IP Right Cessation
- 2010-04-15 IL IL205114A patent/IL205114A/en active IP Right Grant
-
2012
- 2012-06-27 US US13/534,158 patent/US20130172990A1/en not_active Abandoned
-
2013
- 2013-06-12 JP JP2013123639A patent/JP5946797B2/en active Active
Patent Citations (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5049153A (en) * | 1989-12-26 | 1991-09-17 | Nakao Naomi L | Endoscopic stapling device and method |
US5403326A (en) * | 1993-02-01 | 1995-04-04 | The Regents Of The University Of California | Method for performing a gastric wrap of the esophagus for use in the treatment of esophageal reflux |
US5716367A (en) * | 1995-10-18 | 1998-02-10 | Nissho Corporation | Catheter assembly for intracardiac suture |
US20020103492A1 (en) * | 1999-05-20 | 2002-08-01 | Kaplan Aaron V. | Methods and apparatus for transpericardial left atrial appendage closure |
US20040193193A1 (en) * | 1999-06-22 | 2004-09-30 | Ndo Surgical, Inc., A Massachusetts Corporation | Tissue reconfiguration |
US20040010245A1 (en) * | 1999-06-22 | 2004-01-15 | Cerier Jeffrey C. | Method and devices for tissue reconfiguration |
US20050245945A1 (en) * | 1999-06-25 | 2005-11-03 | Usgi Medical Inc. | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US20050192629A1 (en) * | 1999-06-25 | 2005-09-01 | Usgi Medical Inc. | Methods and apparatus for creating and regulating a gastric stoma |
US20040225183A1 (en) * | 1999-06-25 | 2004-11-11 | Usgi Medical | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US6921361B2 (en) * | 2000-07-24 | 2005-07-26 | Olympus Corporation | Endoscopic instrument for forming an artificial valve |
US20020078967A1 (en) * | 2000-12-06 | 2002-06-27 | Robert Sixto | Methods for the endoluminal treatment of gastroesophageal reflux disease (GERD) |
US8062314B2 (en) * | 2000-12-06 | 2011-11-22 | Ethicon Endo-Surgery, Inc. | Methods for the endoluminal treatment of gastroesophageal reflux disease (GERD) |
US7727246B2 (en) * | 2000-12-06 | 2010-06-01 | Ethicon Endo-Surgery, Inc. | Methods for endoluminal treatment |
US6808491B2 (en) * | 2001-05-21 | 2004-10-26 | Syntheon, Llc | Methods and apparatus for on-endoscope instruments having end effectors and combinations of on-endoscope and through-endoscope instruments |
US20020198549A1 (en) * | 2001-06-25 | 2002-12-26 | Syntheon, Llc | Surgical clip |
US20040138682A1 (en) * | 2002-07-11 | 2004-07-15 | Olympus Optical Co., Ltd. | Endoscopic suture apparatus |
US20050119524A1 (en) * | 2002-08-07 | 2005-06-02 | Olympus Optical Co., Ltd. | Endoscopic treatment system |
US20040044364A1 (en) * | 2002-08-29 | 2004-03-04 | Devries Robert | Tissue fasteners and related deployment systems and methods |
US20040059354A1 (en) * | 2002-09-20 | 2004-03-25 | Smith Kevin W. | Surgical fastener particularly for the treatment of gastroesophageal reflux disease (GERD) |
US7618426B2 (en) * | 2002-12-11 | 2009-11-17 | Usgi Medical, Inc. | Apparatus and methods for forming gastrointestinal tissue approximations |
US20040147958A1 (en) * | 2002-12-11 | 2004-07-29 | Usgi Medical | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US20060178560A1 (en) * | 2003-01-15 | 2006-08-10 | Usgi Medical, Inc. | Endoluminal tool deployment system |
US20040193185A1 (en) * | 2003-03-25 | 2004-09-30 | Inscope Development, Llc | Surgical jaw assembly with increased mechanical advantage |
US20050272977A1 (en) * | 2004-04-14 | 2005-12-08 | Usgi Medical Inc. | Methods and apparatus for performing endoluminal procedures |
US20050251166A1 (en) * | 2004-05-07 | 2005-11-10 | Usgi Medical Inc. | Tissue manipulation and securement system |
US7736374B2 (en) * | 2004-05-07 | 2010-06-15 | Usgi Medical, Inc. | Tissue manipulation and securement system |
US20060178562A1 (en) * | 2005-02-10 | 2006-08-10 | Usgi Medical Inc. | Apparatus and methods for obtaining endoluminal access with a steerable guide having a variable pivot |
US20070093857A1 (en) * | 2005-10-26 | 2007-04-26 | Campbell Rogers | Devices and methods for treating mitral valve regurgitation |
US20070142849A1 (en) * | 2005-12-16 | 2007-06-21 | Usgi Medical, Inc. | Helical tissue manipulation instruments and methods of use |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8197464B2 (en) | Deflecting guide catheter for use in a minimally invasive medical procedure for the treatment of mitral valve regurgitation | |
US8226709B2 (en) | Method and system for plicating tissue in a minimally invasive medical procedure for the treatment of mitral valve regurgitation | |
AU2009302496B2 (en) | Plication device with formable linear fastener for use in the direct plication annuloplasty treatment of mitral valve regurgitation | |
AU2015203584B2 (en) | Deflecting guide catheter for use in a minimally invasive medical procedure for the treatment of mitral valve regurgitation | |
AU2015264952A1 (en) | Method and system for plicating tissue in a minimally invasive medical procedure for the treatment of mitral valve regurgitation | |
AU2013202543A1 (en) | Method and system for plicating tissue in a minimally invasive medical procedure for the treatment of mitral valve regurgitation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |